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 Microtubules (MTs) are important components of the eukaryotic cytoskeleton,  
with critical functions in intracellular trafficking, establishing and maintaining cell 
morphology, and segregating chromosomes during mitosis. MTs are hollow, cylindrical 
polymers composed of -tubulin heterodimers. The longitudinal assembly of -tubulin 
subunits generates protofilaments, and multiple protofilaments (typically 13 in vivo) 
interact laterally to form the wall of the MT. In vitro, the polymerization of MTs proceeds in 
two steps: nucleation and elongation. During the nucleation phase, several -tubulin 
subunits associate to form a seed, from which further MT elongation then occurs. However, 
at the relatively low -tubulin concentrations found in vivo, the spontaneous assembly of 
MTs is not favoured, due largely to the slow kinetics of MT nucleation.  
 The nucleation of MTs in vivo requires the -tubulin complex (-TuC), a ring-like 
complex composed of -tubulin and -tubulin complex proteins (GCPs). Two copies of -
tubulin associate with one copy each of GCP2 and GCP3 to produce the -tubulin small 
complex (-TuSC). Multiple -TuSCs, along with the additional GCPs 4,5, and 6, assemble to 
form the larger -tubulin ring complex (-TuRC).  The -TuRC contains a ring of 13 -tubulins, 
which acts as a template for the nucleation of MTs. Typically, the -TuC nucleates MTs only 
when localized to specific subcellular sites, referred to as microtubule organizing centres 
(MTOCs).  However, the precise mechanism by which the -TuC is activated at MTOCs 
remains unknown.  
 In fission yeast, the proteins Mto1 and Mto2 form a complex (Mto1/2) required for 
the nucleation and organization of cytoplasmic MTs.  Mto1/2 determines sites of MT 
nucleation by recruiting the -TuC to several different MTOCs. Different sequences in the 
Mto1 C-terminus independently confer -TuC localization to spindle pole bodies, MTs, and 
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the cell equator.  Here, I show that the Mto1 N-terminus is necessary for localization to the 
nuclear envelope (NE). By simultaneously removing the N- and C-terminal localization 
domains, I generated the "Mto1-bonsai" mutant, which fails to localize to any conventional 
MTOCs. In mto1-bonsai cells, MTs are still nucleated in the cytoplasm in an Mto1-
dependent manner, but nucleation is spatially random. This reveals that targeting of the -
TuC to conventional MTOCs is not necessary for MT nucleation, and suggests that Mto1/2 
has a direct role in activating MT nucleation by the -TuC. Live-cell confocal microscopy 
allows us to detect individual MT nucleation events, in which newly nucleated MTs are 
associated with single -TuCs as well as Mto1/2-bonsai complexes. Fluorescence 
quantification reveals that these nucleating complexes contain approximately 13 molecules 
of both Mto1-bonsai and Mto2, matching the 13 copies of  -tubulin anticipated for a single 
-TuC. We propose that Mto1/2 may contribute to -TuC activation by promoting -TuSC 
assembly and/or inducing conformational changes in the -TuC upon binding. I also 
expressed and purified recombinant Mto1/2-bonsai complex, using a baculovirus/insect cell 
system. This recombinant Mto1/2-bonsai self-assembles into higher-order complexes, 
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1.1 Microtubules are dynamic polymers with a variety of 
cellular functions 
 
 Microtubules (MTs) are vital components of the eukaryotic cytoskeleton and are 
essential for a variety of activities, including intracellular trafficking, maintenance of cell 
morphology, and segregation of chromosomes during cell division. MTs are hollow, 
cylindrical polymers  composed of heterodimers of -tubulin and -tubulin, two proteins 
with significant primary sequence conservation and nearly identical 3-dimenstional 
structures (Burns, 1991; Lowe et al., 2001; Nogales et al., 1998).  MTs polymerize with a 
specific polarity, with -tubulin exposed at the growing (so-called plus) end and -tubulin 
exposed at the opposite (so-called minus) end. Importantly, MTs are found to switch 
between periods  of slow growth and rapid disassembly, a feature referred to as dynamic 
instability (Mitchison and Kirschner, 1984a; Mitchison and Kirschner, 1984b). The dynamic 
and polar properties of MTs are essential to their cellular functions: cell division and 
differentiation rely on dynamic re-modelling of the MT cytoskeleton, while features such as 
cell shape, polarity, and organization are largely defined by the polarity of microtubules. A 
variety of proteins interact with MTs. These proteins, generally referred to as microtubule 
associated proteins (MAPs), have roles in regulating the assembly and organization of MTs, 
and also in mediating MT functions within the cell.   
 MTs are perhaps most recognizable for their role in cell division. In proliferating 
animal cells, interphase MTs are generally arranged as a radial array with minus-ends 
anchored at the centrosome and plus-ends extending towards the cell periphery. As cells 
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enter mitosis, interphase MTs disassemble and give rise to the mitotic spindle, the bipolar 
MT array that segregates duplicated chromosomes into daughter cells prior to cell division. 
This process relies on a particular arrangement of MTs, with minus-ends focused at spindle 
poles and plus-ends available for the capture of chromosomes. This focusing of minus-ends 
requires MTs to be cross-linked and aligned, a process regulated by the activity of motor 
proteins, such as the plus-end directed kinesin Eg5 and minus-end directed dynein (Gaglio 
et al., 1996; Sawin et al., 1992). MTs within the mitotic spindle are highly dynamic, a feature 
which may increase the frequency with which MTs encounter and bind chromosomes. 
Work in Xenopus laevis egg extracts has revealed that the high turnover of spindle MTs may 
arise from the antagonistic activities of XMAP215 and XKCM1, MAPs which promote MT 
polymerization and depolymerization, respectively (Tournebize et al., 2000). Other factors, 
including the Ndc80 complex, mediate attachment of MT plus-ends to kinetochore sites on 
chromosomes (DeLuca and Musacchio, 2012). MTs become stabilized upon association with 
kinetochores (Zhai et al., 1995), thereby allowing chromosomes to be pulled towards the 
spindle poles in a process thought to involve both motor proteins and MT depolymerization 
(Mitchison, 2005). This coordinated activity of MTs, MAPs, and motor proteins is 
characteristic of the manner in which MTs are employed within the cell. 
 MTs also provide the tracks along which motor proteins transport vesicles and 
organelles in an ATP-dependent manner, a process first directly observed in cytoplasm 
isolated from the squid giant axon (Vale et al., 1985a; Vale et al., 1985b). The correct 
positioning and morphology of the golgi complex, for example, depends on interaction with 
centrosomal MTs as well as MTs originating from the golgi membranes themselves (Miller 
et al., 2009). Membrane trafficking in exocytosis and endocytosis relies on MT-mediated 
transport by kinesins and the dynein-dynactin complex.  Trafficking of membranes amongst 
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organelles, such as the endoplasmic reticulum and golgi complex, similarly involves MTs 
and associated motor proteins (Caviston and Holzbaur, 2006).  
 Other organelles, including the nucleus and mitochondria, are also positioned by 
MTs (Yaffe et al., 1996) . In fission yeast, MTs are organized with plus-ends oriented 
towards the cell tips, and  minus ends on or near the nuclear envelope (NE). A balance of 
forces produced as MTs polymerize and push against the cell cortex is thought to position 
the nucleus in the centre of the cell (Tran et al., 2001). Nuclear positioning in animal cells 
likely occurs by a similar mechanism, but may also involve the activity of motor proteins 
(Morris, 2003; Reinsch and Gonczy, 1998).  
 Both the actin and MT cytoskeleton are important to the establishment and 
maintenance of cell polarity, a process involved in cell morphogenesis, differentiation, and 
division (Li and Gundersen, 2008). Regions of cell growth and protrusion are associated 
with dynamic changes in the actin cytoskeleton, as observed in the focal adhesions of 
migrating cells (Small and Kaverina, 2003)  and axonal growth cones of neurons (Kalil and 
Dent, 2004). In processes mediated by various proteins that associate with MT plus-ends, 
MTs are linked to the cell cortex, where they appear to be involved in regulating the actin 
cytoskeleton.  In fission yeast, for example, the MT plus-end proteins Tea1p and Tea4p are 
required for the recruitment of the formin For3p, an activator of actin nucleation, to 
growing cell tips (Snaith and Sawin, 2005).  
 
 
1.2 Microtubule polymerization 
 
 Heterodimers of -tubulin assemble in a longitudinal, head-to-tail manner to 
generate MT protofilaments. Separate lateral interactions between parallel protofilaments 
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generate the cylindrical, polar structure of the microtubule. In vivo, MTs are typically 
composed of 13 protofilaments. MTs with 9-16 protofilaments have also been observed, 
although these more variable numbers of protofilaments are usually only observed when 
MTs are assembled in vitro. (Chretien and Wade, 1991; Evans et al., 1985; Tilney et al., 
1973).  In a 13-protofilament MT, individual protofilaments are effectively parallel to the 
axis of the MT itself. However, - and -tubulin monomers within the MT lattice follow a 
three-start, left-handed helix, meaning each turn around the helix axis corresponds to a rise 
of  three monomers. As a consequence, MTs have a "seam" where lateral interaction 
between unlike - and -tubulin subunits occurs (Li et al., 2002; Mandelkow et al., 1986).   
 The polymerization of MTs in vitro was first demonstrated using tubulin partially 
purified from rat brains, and was found to require the presence of GTP, magnesium, and 
calcium chelators (Weisenberg, 1972). Early studies suggested that steady-state MTs 
undergo a process referred to as treadmilling, whereby the addition of tubulin subunits at 
one end of the polymer is balanced by tubulin loss at the other end (Margolis and Wilson, 
1978). This interpretation, however, was based on the bulk analysis of  populations of MTs 
in vitro. Subsequent analysis of the length distributions of individual, fixed MTs led to the 
"dynamic instability" model of MT dynamics, which remains generally accepted today 
(Mitchison and Kirschner, 1984a; Mitchison and Kirschner, 1984b). In essence, this model 
proposes that the plus-ends of individual MTs switch between states of slow assembly and 
rapid disassembly. MT minus ends can also polymerize and depolymerize. In vivo, however, 
MT minus ends are significantly more stable than MT plus ends. It was later determined 
that -tubulin, rather than-tubulin, was exposed at the more dynamic MT plus-end 
(Mitchison, 1993).  
  The dynamic instability of MTs is ultimately fuelled by hydrolysis of -tubulin-bound 
GTP. Both - and -tubulin bind a single molecule of GTP, although only the GTP associated 
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with -tubulin undergoes hydrolysis and exchange . As a new -tubulin subunit is added 
to a MT, residues present on the newly-arrived -tubulin catalyze hydrolysis of GTP on the 
receiving -tubulin (Nogales et al., 1999). The resulting GDP is buried at the subunit 
interface, and can therefore no longer be exchanged. Importantly, though, MT 
polymerization can occur in the in the presence of the non-hydrolysable GTP analogue 
GMPCPP, revealing that GTP hydrolysis itself is not required for subunit addition (Hyman et 
al., 1992).  
 In fact, GMPCPP-microtubules are observed to be hyper-stable, thus implicating 
GTP hydrolysis in MT depolymerization. Indeed, hydrolysis of GTP in the MT lattice results 
in curving of protofilaments, which destabilizes the lattice and promotes MT 
depolymerization. Using electron microscopy (EM), these curved protofilaments have been 
directly observed at the ends of depolymerizing MTs (Arnal et al., 2000; Muller-Reichert et 
al., 1998). By contrast, GTP-bound protofilaments have a straight conformation and appear 
to grow as sheets which close to produce MTs with blunt-ends (Arnal et al., 2000; Chretien 
et al., 1995). In addition, GDP-tubulin is found to dissociate from MT plus-ends at a rate 2-3 
orders of magnitude faster than GTP-tubulin (Mitchison and Kirschner, 1984a).  
 Taken together, these observations reveal an elegant model for the dynamic 
instability of MTs. As a MT polymerizes, GTP-bound subunits are added to the growing plus-
end at a rate that exceeds GTP hydrolysis. As a result, the MT plus-end develops a "cap" of 
GTP-tubulin subunits (Mitchison and Kirschner, 1984a). The remainder of the MT, which 
may be composed mostly of GDP-tubulin, is protected from depolymerization by the GTP 
cap (Caplow and Shanks, 1996). However, the GTP cap can be lost if the rate of hydrolysis 
overtakes the rate of subunit addition due, for example, to a drop in the concentration of 
free GTP-tubulin. This results in a loss of GDP-tubulin from the MT end, curving of 
protofilaments, and ultimately MT disassembly, a process referred to as catastrophe. In 
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contrast, rescue events occur when GTP subunits are added to the end of a depolymerizing 
MT, resulting in a re-initiation of growth. These cycles of polymerization and 
depolymerization, fuelled by energy from GTP hydrolysis, allow MTs to do useful work 
within the cell.  
 In vitro, MT polymerization occurs in two steps, referred to as nucleation and 
elongation. During the nucleation stage, several -tubulin subunits associate to form a 
seed from which further polymerization then occurs. At low tubulin concentrations (<10 
M), disassembly of these MT seeds is greatly favoured over assembly, resulting in limited 
MT polymerization (Kuchnir Fygenson et al., 1995; Mitchison and Kirschner, 1984b). 
However, once a sufficient number of tubulin subunits are assembled, polymerization 
becomes energetically favourable, and MT elongation  proceeds rapidly. Most likely, this is 
because tubulin subunits within the MT lattice are stabilized, and have their conformation 
restricted, by both lateral and longitudinal interactions with one another (Gardner et al., 
2011; Rice et al., 2008).  
 
 
1.3 Microtubule organizing centres  
 
  In vivo, specialized sites referred to as microtubule organizing centres (MTOCs) 
allow cells to surmount the kinetic barrier imposed by MT nucleation. These sites contain 
factors, including -tubulin and its associated proteins (see below),  which promote 
localized MT assembly. Therefore, by maintaining relatively low tubulin concentrations, at 
which spontaneous assembly of MTs is not favoured, cells can employ MTOCs to determine 
where and when MT polymerization occurs. As a result, MTOCs ensure that MTs are 
arranged and oriented in a manner that is useful to the cell. Generally, MT minus ends are 
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anchored at MTOCs, with plus-ends projecting outwards. MTOCs vary amongst species and 
throughout stages of cell division and differentiation, but can generally be categorized as 
either centrosomal or acentrosomal.  
 Purified centrosomes are capable of promoting MT nucleation at tubulin 
concentrations significantly lower than those required for spontaneous MT assembly in 
vitro (Mitchison and Kirschner, 1984b). In many animal cells, the centrosome acts as the 
principal MTOC, nucleating radial arrays of MTs during interphase, and the mitotic spindle 
during mitosis.  The centrosome consists of a pair of centrioles, which are linked by fibrous 
proteins and surrounded by a matrix of proteins referred to as the pericentriolar material 
(PCM). The PCM is composed largely of coiled-coil proteins from the pericentrin and 
AKAP450 families and acts to anchor components required for MT nucleation, including -
tubulin (Azimzadeh and Bornens, 2007; Bettencourt-Dias and Glover, 2007). Centrioles 
themselves are composed of an ordered, cylindrical array of 9 MT triplets but do not have a 
direct role in the nucleation of centrosomal MTs. Rather, centrioles appear to anchor the 
minus-ends of MTs nucleated from the PCM, in a process involving the protein ninein 
(Mogensen et al., 2000).  In addition, centrioles can migrate to the plasma membrane, 
where they give rise to basal bodies which nucleate the axonemal MTs of cilia and flagella 
(Beisson and Wright, 2003). Animal cells in which the centrosomes have been destroyed by 
laser microsurgery retain the ability to assemble a mitotic spindle, revealing that 
centrosomes are not essential to MT nucleation or spindle assemble (Khodjakov et al., 
2000).    
 In fact, centrioles and centrosomes are absent in both higher plants and fungi. 
However, fungi contain an analogous structure, the spindle pole body (SPB), which is 
embedded in the NE. EM in budding and fission yeast has revealed that the SPB consists of 
3 primary layers, an outer layer which faces the cytoplasm, a central layer which spans the 
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NE, and an inner layer which faces the nucleoplasm (McIntosh and O'Toole, 1999; O'Toole 
et al., 1999).  These layers are composed of structural proteins, including Spc42 and 
calmodulin/Cmd1, as well as proteins involved in SPB duplication, membrane insertion, and 
MT nucleation (Jaspersen and Winey, 2004). Cytoplasmic MTs are nucleated from the outer 
layer of the SPB, while the mitotic spindle is nucleated from inner layers following SPB 
duplication.   In the budding yeast Saccharomyces cerevisiae, the SPB serves as the sole site 
of both interphase and spindle MT nucleation (Knop et al., 1999). In fission yeast, on the 
other hand, MTs are nucleated from SPBs as well as from additional sites on the NE, along 
existing MTs, and at the cell equator during cell division (Hagan, 1998; Sawin and Tran, 
2006).  
 Acentrosomal (and non-SPB) MTOCs allow cells to generate a diversity of MT 
arrays, independent of a central organizing structure.  In plants, for example, MTs are 
nucleated from sites on the NE and cell cortex, as well as from the sides of existing MTs 
(Ehrhardt and Shaw, 2006; Murata et al., 2005).  Isolated plant nuclei are capable of 
promoting MT assembly, indicating that MT-nucleating material is directly associated with 
the NE (Seltzer et al., 2007; Stoppin et al., 1994). The NE also acts as a MTOC in myotubes, 
the multinucleate cells formed by myoblast fusion during skeletal muscle differentiation 
(Tassin et al., 1985).  During this differentiation process, centrosomal proteins, including -
tubulin, pericentrin, and ninein, are re-distributed to the nuclear surface, thereby re-
defining sites of MT nucleation (Bugnard et al., 2005).  
 Other differentiated cells, such as neurons and epithelial cells, contain both 
centrosomal and acentrosomal MTOCs.  In neuronal cells, MTs in the cell body are often 
associated with the centrosome, while MTs within dendrites and axons are organized in an 
acentrosomal fashion. MTs are critical for the development of axonal and dendritic 
extensions, and  also facilitate the transport of cargo related to synaptic transmission 
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(Goldstein and Yang, 2000). As neuronal differentiation progresses, the centrosome loses 
its function as a MTOC, and acentrosomal MT assembly alone appears to be sufficient for 
promoting axon growth and regeneration (Stiess et al., 2010).  
 Polarized epithelial cells exhibit two fairly distinct acentrosomal MT arrays, in 
addition to the limited number of MTs generally associated with the centrosome. In the 
first type of acentrosomal array, MTs are arranged in parallel along the apico-basal axis, 
with minus ends anchored at the apical membrane (Waschke and Drenckhahn, 2000). The 
second array consists of a network of MTs that are associated with the basal cortex and 
exhibit mixed polarity (Reilein and Nelson, 2005). -tubulin has been observed at these 
acentrosomal MTOCs, although there remains no direct evidence for de novo MT 
nucleation from these sites (Reilein et al., 2005; Waschke and Drenckhahn, 2000). Rather, 
these MTs may be nucleated at the centrosome, released into the cytoplasm, and 
subsequently capture at cortical sites (Mogensen, 1999).  
 
 
1.4 The -tubulin complex 
 
  It is evident that MT organization varies greatly across species and throughout 
stages of cell division and differentiation. Nonetheless, efficient MT nucleation at all MTOCs 
ultimately requires -tubulin. First discovered in Aspergillus nidulas, -tubulin is a 
homologue of -tubulin that is conserved amongst eukaryotes (Oakley and Oakley, 1989; 
Stearns et al., 1991; Zheng et al., 1991). X-ray crystallography has revealed that the 
structure of -tubulin is very similar to the structures of - and -tubulin (Aldaz et al., 2005; 
Rice et al., 2008). Significantly, these structures also indicate that -tubulins associate with 
one another via lateral interactions, using the same surfaces involved in -tubulin lateral 
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interactions in the MT lattice. Longitudinal interactions between -tubulin and a-tubulin 
could, therefore, stabilize lateral interactions between -tubulin subunits and promote 
MT assembly.  
 Early work in Drosophila and Xenopus egg extracts demonstrated that -tubulin 
associates with a variety of  evolutionarily conserved proteins, specifically the -tubulin 
complex proteins (GCPs) GCP2, GCP3, GCP4, GCP5, and GCP6 (Oegema et al., 1999; Zheng 
et al., 1995) [the GCP nomenclature is used throughout for convenience, but species-
specific names for GCPs do exist (Table 1.1)]. Electron microscopy of these complexes 
revealed that they are ring-like structures, leading to the term "-tubulin ring complex" (-
TuRC). These structures associate  with the minus ends of MTs, and have a helical pitch and 
diameter approximately matching a MT (Moritz et al., 2000; Zheng et al., 1995).   In vitro, -
TuRCs are capable of nucleating MT assembly. However, under high-salt conditions, the -
TuRC was found to disassemble into smaller complexes consisting of only -tubulin, GCP2, 
and GCP3. These smaller complexes, appropriately named -tubulin small complexes (-
TuSCs), lacked the ability to promote MT polymerization (Oegema et al., 1999). Low-
resolution 3-dimensional structures of the -TuRC, derived from EM tomography, appeared 
to consist of repeating V-shaped -TuSCs arranged around a "cap" structure, which was 
presumed to represent the additional GCPs (Moritz et al., 2000).  Overall, these studies 
suggested a "template model" in which multiple -TuSCs are assembled to produce a -
TuRC, thereby generating a ring of -tubulins that acts as a template for MT assembly.  
 
Table 1.1: -tubulin complex protein nomenclature in various species.  
Human D. melanogaster Xenopus A. thaliana S.  cerevisiae S. pombe A. nidulans 
-tubulin -tubulin -tubulin -tubulin Tub4p Tubg1/Gtb1 mipA 
hGCP2 Dgrip84 Xgrip110 AtSpc97p Spc97p Alp4 AnGCP2 
hGCP3 Dgrip91 Xgrip109 AtSpc98p Spc98p Alp6 AnGCP3 
hGCP4 Dgrip75 Xgrip76 AtGCP4 - Gfh1 AnGCP4§ 
hGCP5 Dgrip128 Xgrip133 AtGCP5 - Mod21 AnGCP5 
hGCP6 Dgrip163 Xgrip210 AtGCP6 - Alp16 AnGCP6 
Adapted from(Wiese and Zheng, 2006) 
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 An alternative "protofilament model" for MT nucleation has also been 
proposed. In this model, the -TuRC unwinds to form a protofilament-like structure, with -
tubulins associating in a longitudinal manner. These -tubulins interact laterally with -
tubulin dimers, stabilizing early protofilaments that can then facilitate further MT 
polymerization (Erickson, 2000; Erickson and Stoffler, 1996). The bulk of current structural 
data, however, strongly favours the template model. 
 Work in S. cerevisiae, which lacks homologues of GCPs 4, 5, and 6, has provided 
a great deal of insight into -TuSC structure and function. The budding yeast -TuSC is a 
stable complex consisting of 4 molecules: one copy of GCP2 (Spc97p in budding yeast), one 
copy of GCP3 (Spc98p in budding yeast), and two copies of -tubulin (Knop et al., 1997; 
Knop and Schiebel, 1997).  Reconstituted -TuSCs, produced using baculovirus/insect cells, 
exhibit the same stoichiometry and sedimentation coefficient (11.6S) as endogenous -
TuSCs (Vinh et al., 2002). These reconstituted complexes have the capacity to bind pre-
formed MTs in vitro, but display only very weak nucleating activity. In budding yeast cells, -
TuSCs promote MT nucleation only when localized to the SPB by the proteins Spc110 and 
Spc72, suggesting that these proteins may be necessary for -TuSC function (Knop and 
Schiebel, 1997; Knop and Schiebel, 1998). Reconstitution of -TuSCs in complex with 
Spc110, however, fails to promote -TuSC multimerization into larger complexes, and does 
not result in increased nucleating activity (Vinh et al., 2002). Interestingly, particular buffer 
conditions allow endogenous budding yeast -TuSC proteins to be isolated as a 22S 
complex, comparable in size to the 25-35S -TuRCs seen in higher eukaryotes (Vinh et al., 
2002). This implies that additional non-GCP factors found in vivo may promote -TuSC 
multimerization and nucleating activity.  
 Following initial biochemical characterization, single particle EM was used to 
determine the structure of recombinant budding yeast -TuSC at 25-Å (Kollman et al., 
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2008). The -TuSC was found to have a Y-shaped structure, with two "arms" roughly 100 Å 
in length each associated with a globular lobe approximately 50 Å in diameter. Gold-
labelling and manually docking of the -tubulin crystal structure revealed that the lobes 
corresponded to -tubulin. Also, in vivo fluorescence resonance energy transfer (FRET), 
coupled with EM analysis of -TuSCs containing CFP and YFP-tagged components, was used 
to determine the relative orientations of proteins within the complex.  The C-termini of  
both GCP2 and GCP3 were found to interact directly with -tubulin, while the N-termini of 
GCP2 and GCP3 overlapped and interacted with one another (Choy et al., 2009; Kollman et 
al., 2008). Importantly, the centre-to-centre spacing between -tubulins within the -TuSC 
was seen to vary from 70-85 Å, owing to flexibility in the GCP3 arm. This distance is 
significantly greater than the 53 Å spacing between adjacent protofilaments in the MT 
lattice, suggesting that conformational changes in the -TuSC may be necessary to generate 
an effective template for MT nucleation (Choy et al., 2009; Kollman et al., 2008).  
 Under specific low-salt buffer conditions, purified -TuSCs are capable of 
assembling into ring structures resembling Drosophila -TuRCs (Kollman et al., 2010). 
Remarkably, -TuSCs co-purified with truncated Spc1101-220, and stabilized by the addition 
of glycerol, can polymerize into elongated filaments with a repeating helical structure. Due 
to the helical symmetry present in these filaments, it was possible to determine their EM 
structure to a high resolution of 8 Å (Kollman et al., 2010). Lateral associations between 
GCP2 and GCP3 of adjacent -TuSCs mediate the assembly of these elongated structures. 
Further, each turn of the helix corresponds to 13 -tubulins or 6 ½ -TuSCs, resulting in a 
half -TuSC overlap. The geometry of the filament therefore approximately matches that of 




 As predicted by the template model, -tubulins associate with GCP2 and GCP3 
through their minus ends, leaving their plus ends available for longitudinal association with 
-tubulin. However, the intra--TuSC spacing of -tubulins in the filament structure does 
not match the lateral spacing of MT protofilaments, as observed with isolated -TuSCs. -
Tubulins in adjacent -TuSCs, by contrast, appear to form lateral contacts that match those 
of the MT lattice. Thus, multimerization of -TuSCs appears to be insufficient for generating 
a potent MT-nucleating complex. Conformational changes would seem to be required to 
turn these -TuSC rings into effective MT nucleators. In fact, a 23o rotation of GCP3 would 
be sufficient to generate a -tubulin template matching the MT lattice spacing (Kollman et 
al., 2010). Such a change could be induced by post-translational modifications or binding of 
additional proteins, although the exact mechanism of -tubulin complex (-TuC) activation 
remains unknown.  
 GCP4, 5, and 6 were previously thought to promote -TuRC assembly by acting 
as a scaffold for -TuSC multimerization. The absence of these proteins in budding yeast, as 
well as the findings described above, clearly reveal that GCP4, 5, and 6 are not required for 
the formation of -tubulin rings or MT nucleation. Further, deletion of the fission yeast 
genes encoding GCPs 4-6 results in only a minor reduction in the frequency of MT 
nucleation (Anders et al., 2006). In D. melanogaster, simultaneous RNAi depletion of GCPs 
4-6 does not inhibit -TuSC localization to the centrosome, but does inhibit localization to 
the spindle. Cells retain the ability to nucleate interphase MTs as well as the mitotic spindle, 
although defects in MT organization are observed (Verollet et al., 2006). Aspergillus 
nidulans similarly does not require GCPs 4-6 for -TuSC localization to the SPB or for normal 
MT nucleation (Xiong and Oakley, 2009). These observations indicate that GCP4, 5, and 6 
are not  strictly required for MT nucleation by the -TuC, but may increase the efficiency of 
nucleation or promote -TuC localization to particular types of MTOCs.  
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 Recently, the crystal structure of human GCP4 (hGCP4) was determined, which 
has helped to clarify the role of GCPs 4-6 in -TuC structure and function (Guillet et al., 
2011). hGCP4 has an elongated structure, consisting of 5 successive helical bundles. This 
crystal structure fits extremely well into the cryo-EM structures of GCP2 and GCP3, 
suggesting a high degree of structural conservation amongst all GCPs. In addition, although 
hGCPs 2-6 vary significantly in length — with GCP4 being the shortest — all show significant 
primary sequence homology (Guillet et al., 2011). Previously, homology identified amongst 
GCPs was mostly limited to two particularly conserved sequences, referred to as gamma 
ring protein motifs (grip motifs) grip1 and grip2 (Gunawardane et al., 2000). The -TuSC 
structure revealed that the grip2 sequence, exposed near the C-terminus of GCP2 and 
GCP3, is likely involved in -tubulin binding (Kollman et al., 2010). grip1 is located towards 
the N-terminus of GCPs, and forms part of the surface involved in GCP lateral interactions. 
Portions of grip1 are also exposed on the outer surface of the -TuSC, suggesting grip1 may 
have an additional role in binding to -TuC-associated proteins (Kollman et al., 2011; 
Kollman et al., 2010). Significantly, the surfaces involved in GCP and -tubulin interaction 
are conserved in the GCP4 structure, and interaction between -tubulin and the GCP4 C-
terminus has been confirmed by immunoprecipitation (Guillet et al., 2011).  
  Overall, these findings imply that all five GCPs share  a similar structure and 
are able to bind to one another as well as to -tubulin. Therefore, it is possible that GCPs 4-
6 associate with one another, GCP2, and GCP3 to form -TuSC-like structures that are 
incorporated into the -TuRC (Kollman et al., 2011) (Figure 1.1). -TuSC-like pairs of all GCPs 
can thus be imagined, although GCPs 4-6 appear to interact with one another (Anders et al., 
2006; Xiong and Oakley, 2009). Biochemical analysis of purified, endogenous human -
TuRCs shows that GCPs 4-6 are present only in limited copy number, with roughly 14 -
tubulins associating with 12 copies of GCP2/3, 2-3 copies of GCP4, 1 copy of GCP5, and 0.5 
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copies of GCP6 (Choi et al., 2010). The observation of 0.5 copies of GCP6 suggests that -
TuRCs may assembly with various stoichiometries of GCPs.  
 Given the ability of -TuSCs to form ring structures and nucleate MTs in vivo, 
the precise function of GCPs 4, 5, and 6 within the -TuRC is still unclear. However, 
biochemical studies of endogenous -TuCs indicate that GCPs 4-6  promote -TuRC stability 
(Verollet et al., 2006; Xiong and Oakley, 2009). It has also been proposed that GCPs 4-6 may 
act to initiate or terminate -TuRC assembly in a manner that limits rings to 13 -tubulins, 






1.5 Localization and regulation of the -tubulin complex 
 
 Fluorescence recovery after photobleaching (FRAP) experiments have 
demonstrated that centrosomal -tubulin exchanges with a pool of free, cytoplasmic -
tubulin (Khodjakov and Rieder, 1999). Additional work in human lymphoblastic cells has 
shown that roughly 80% of -TuCs exist in this cytosolic form (Moudjou et al., 1996). 
However, ectopic MT nucleation is generally not observed, with -TuC activity being limited 
to specific MTOCs. This suggests that factors present at MTOCs activate the -TuC, perhaps 
by mediating the conformation changes necessary to generate an effective nucleator. A 
variety of proteins are involved in recruiting the -TuC to MTOCs, although the role of these 
proteins in activating the -TuC remains unclear.  
 The GCP-WD/NEDD1 family of proteins is involved in -TuC localization in 
plants and animals, but is absent in fungi (Gunawardane et al., 2003; Luders et al., 2006; 
Zeng et al., 2009). Despite lacking grip motifs, GCP-WD is generally considered to be a 
genuine -TuC component. Dgp71WD, the Drosophila GCP-WD homologue,  associates with 
all 5 grip motif-containing GCPs, as well as -tubulin itself (Gunawardane et al., 2003). 
Association with -tubulin, as well as GCP-WD multimerization, is mediated by residues in 
the GCP-WD C-terminus (Manning et al., 2010). The GCP-WD N-terminus, on the other 
hand, is composed of WD40 repeats, which are predicted to form a -propeller structure 
involved in protein interaction. It has thus been proposed that GCP-WD may act as a 
scaffold to promote -TuC assembly, although GCP-WD depletion has only a small effect on 
the formation of -TuRCs (Haren et al., 2006). Nonetheless, GCP-WD is critical for -TuC 
localization to both centrosomes and spindle MTs. Depletion of GCP-WD inhibits 
centrosomal and chromatin-mediated MT nucleation, thus preventing mitotic spindle 
formation (Haren et al., 2006; Luders et al., 2006). By contrast, -tubulin is not required for 
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GCP-WD localization to centrosomes, indicating that GCP-WD is a bona fide -TuC targeting 
factor (Haren et al., 2006).  
 Like GCP-WD, GCP8/MOZART2 lacks homology to GCPs 2-6 but appears to be a 
stable member of the -TuC (Hutchins et al., 2010; Teixido-Travesa et al., 2010). GCP8 is a 
small 16 kDa protein that is conserved almost exclusively amongst deuterostomes, and its 
study has been limited to human cells. Depletion of GCP8 by siRNA impairs -TuC 
localization to interphase centrosomes, and results in reduced centrosomal MT nucleation 
during interphase. Mitotic -TuC localization and MT nucleation, however, are unaffected 
by GCP8 depletion. Also, as seen with GCP-WD, -TuRC assembly does not depend on GCP8, 
perhaps suggesting a regulatory rather than structural role for GCP8 (Teixido-Travesa et al., 
2010). MOZART1, a candidate -TuC component conserved amongst lower eukaryotes such 
as fission yeast, appears to have a role in spindle assembly and targeting of the -TuC to 
mitotic centrosomes (Hutchins et al., 2010).  
 The -TuC also associates with a variety of PCM components, many of which 
are large coiled-coil proteins. For example, -tubulin and pericentrin associate in an 
elaborate lattice structure at the centrosome that is associated with MTs. This lattice 
gradually increases in size as cells enter mitosis, and then rapidly disassembles (Dictenberg 
et al., 1998). Coimmunoprecipitation suggests that pericentrin may associate with the -
TuRC via interactions with GCP2 and GCP3 (Zimmerman et al., 2004). The centrosomal 
proteins Kendrin and AKAP450 also form complexes with GCPs, and disruption of either 
protein interferes with MT nucleation (Takahashi et al., 2002). It is uncertain, however, 
whether or not these proteins interact directly with the -TuC to mediate centrosomal 
attachment. Instead, they may simply be involved in the overall assembly of the PCM.  
 In budding yeast, localization of -TuSC proteins to the nuclear and cytoplasmic 
face of the SPB is mediated by Spc110 and Spc72, respectively (Knop and Schiebel, 1997; 
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Knop and Schiebel, 1998). Both proteins are predicted to contain coiled-coils, as with many 
centrosomal proteins, and interact with the -TuSC via an N-terminal domain. As described 
above, a fragment of Spc110 is able to promote -TuSC multimerization in vitro, but fails to 
significantly enhance -TuSC nucleating activity (Kollman et al., 2010).  
 The centrosomal protein CDK5RAP2 is of particular interest, as it appears to 
have roles in both -TuC localization and activation. CDK5RAP2 is a relatively large (1893 
amino acid) coiled-coil protein that contributes to centrosomal -TuC recruitment and MT 
nucleation, but does not appear to have a role in -TuRC assembly (Fong et al., 2008). 
Interaction between CDK5RAP2 and the -TuC is mediated by a short stretch of 
approximately 50 amino acids, referred to as centrosomin motif 1 (CM1). The CM1 region is 
conserved amongst animal and fungal cells, and is generally found towards the N-terminus 
of proteins predicted to contain coiled-coils. CM1 proteins, including Drosophila 
Centrosomin (Cnn), human Myomegalin and CDK5RAP2, as well as fission yeast Mto1 and 
Pcp1, have various roles in centrosome function, MT organization,  and brain development 
(Bond et al., 2005; Flory et al., 2002; Fong et al., 2008; Megraw et al., 1999; Samejima et al., 
2008; Sawin et al., 2004; Verde et al., 2001). In vivo, over-expression of the CDK5RAP2 CM1 
fragment causes -tubulin to be de-localized from the centrosome, and promotes 
acentrosomal MT nucleation (Choi et al., 2010; Fong et al., 2008). Further, both full-length 
CDK5RAP2 and a CM1-containing fragment are capable of enhancing MT nucleation by 
purified -TuRCs in vitro (Choi et al., 2010). These findings suggest that CDK5RAP2  is a -






1.6 Microtubule organization in fission yeast  
 
 Owing to its relatively simple arrangement of MTs,  the fission yeast 
Schizosaccharomyces pombe is an attractive model for the study of MT dynamics and 
organization.   Fission yeast exhibit a diversity of MTOCs, which vary throughout the cell 
cycle (Hagan, 1998; Sawin and Tran, 2006) (Figure 1.2A). During interphase, fission yeast 
cells contain roughly 3-5 MT bundles, which are arranged with plus ends oriented towards 
the cell tips and minus ends near the nucleus. These interphase MTs contribute to nuclear 
positioning, as well as the establishment of cell polarity, helping to define the characteristic 
rod shape of S. pombe (Hagan and Hyams, 1988; Sawin and Snaith, 2004; Tran et al., 2001). 
Interphase MT nucleation occurs from the SPB and from interphase MTOCs (iMTOCs) on 
the NE and along existing MTs. Anti-parallel bundling and minus end-directed sliding of MTs 
helps to focus minus ends around the nuclear envelope. Bundling proteins such as Ase1 and 
Dis1, as well as the minus end-directed motor Klp2, facilitate this process (Carazo-Salas and 
Nurse, 2006; Roque et al., 2010).   
 As fission yeast cells enter mitosis, interphase MTs depolymerize. MTs are then 
nucleated form the nucleoplasmic face of the duplicated SPBs, ultimately giving rise to a 
mitotic spindle that spans the nucleus at metaphase. Fission yeast undergo a closed mitosis, 
such that NE breakdown does not occur. As anaphase proceeds, the spindle elongates to 
span the long axis of the cell, acting to segregate chromosomes and achieve nuclear 
separation (Hagan and Yanagida, 1997; Hagan and Hyams, 1988).  Astral MTs, nucleated 
from the cytoplasmic face of the SPBs, are thought to align the mitotic spindle by pushing 




 During late anaphase, MTs are nucleated from the equatorial  MTOC (eMTOC), 
generating a post-anaphase array (PAA) of MTs at the site of septation/cytokinesis. Septum 
formation and cell division require the contractile actin-myosin ring, which is positioned at 
the centre of the cell in order to ensure accurate division into two identical daughter cells 
(Feierbach and Chang, 2001). The position of the contractile ring is defined by the pre-
divisional nucleus, in a process whereby the protein Mid1 is released from the nucleus onto 
the adjacent cell cortex (Daga and Chang, 2005). The position of Mid1 defines the site for 
subsequent recruitment of myosin and other contractile ring components (Wu et al., 2003).  
The position of the eMTOC, in turn, is defined by the actin-myosin contractile ring. PAA MTs 
then ensure that the contractile ring remains positioned at the centre of the cell as cells 
progress through cytokinesis (Pardo and Nurse, 2003). The PAA may also have a role in re-
positioning the nucleus towards the centre of the cell following cell division (Hagan and 
Yanagida, 1997).  
 The nucleation of spindle MTs in fission yeast is mediated by the essential protein 
Pcp1, which recruits the -TuC to the nucleoplasmic face of the SPB (Flory et al., 2002; Fong 
et al., 2010). Pcp1 is a coiled-coil protein containing the conserved -TuC-binding CM1 
domain (Samejima et al., 2008). A temperature-sensitive pcp1 mutant, which includes a 
point mutation within the CM1 region, inhibits -TuC localization to mitotic SPBs. This 
results in defective spindle formation and chromosome missegregation (Fong et al., 2010).  
A separate pcp1 mutant, which also exhibits spindle defects, is deficient in polo kinase 
(Plo1) recruitment to SPBs. Given that Plo1 accumulation at SPBs is associated with mitotic 
entry and septum formation, this suggests an additional role for Pcp1 in cell-cycle 












1.7 The Mto1/2 complex and cytoplasmic MT organization 
 
 In fission yeast, the proteins Mto1 and Mto2 are required for the assembly and 
organization of cytoplasmic MTs (Figure 1.2). Mto1 and Mto2 associate to form the Mto1/2 
complex, which recruits the -TuC to iMTOCs, the eMTOC, and  the cytoplasmic face of the 
SPB during both interphase and mitosis (Samejima et al., 2005; Sawin et al., 2004; 
Venkatram et al., 2005; Venkatram et al., 2004). Deletion of either mto1 or mto2 results in 
cells with abnormal interphase MT arrays, typically consisting of 1-2 long bundles which 
curve around the cell tips. This lack of proper MT organization results in defective nuclear 
positioning, as well as polarity defects which give cells a characteristic curved shape.   
 In wild-type cells, both Mto1 and Mto2 co-localize with the -TuC at cytoplasmic 
MTOCs. In mto1 cells, by contrast, localization of Mto2 and the -TuC to cytoplasmic 
MTOCs is abolished, although the -TuC is still localized to the nucleoplasmic face of the 
SPB in a process depending on Pcp1 (Flory et al., 2002; Samejima et al., 2005; Sawin et al., 
2004; Venkatram et al., 2005; Venkatram et al., 2004). Live-cell imaging reveals that cells 
lacking Mto1 are completely deficient in de novo cytoplasmic MT nucleation, and therefore 
fail to assemble interphase, PAA, and astral MTs.  In cold-shock experiments, in which cells 
are chilled to depolymerize MTs and subsequently  warmed to allow MT re-growth, wild-
type cells nucleate new MTs within 1 minute. mto1 cells, on the other hand, only exhibit 
cytoplasmic MTs after 10-15 minutes. These MTs likely originate from the nucleoplasmic 
face of the SPB and subsequently escape into the cytoplasm, thus accounting for the 
unusual interphase arrays observed in mto1 cells (Sawin et al., 2004; Venkatram et al., 
2004).  
 In an mto2 background, cells lack iMTOCs on the NE and MTs, and interphase MTs 
are nucleated exclusively from the SPB. Cells lacking Mto2 also retain the ability to nucleate 
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astral and PAA MTs, although nucleation from the eMTOC is significantly impaired 
(Samejima et al., 2005; Venkatram et al., 2005). The -TuC localizes normally to SPBs in 
mto2 cells, but is absent from sites along MTs and only faintly detectable at the eMTOC 
(Samejima et al., 2005). Similarly, Mto1 localization to SPBs is unaffected in a mto2 
background, although reduced levels of Mto1 are observed on MTs and at the eMTOC. 
Over-expression of Mto1 is sufficient to rescue Mto1 localization to cytoplasmic MTOCs in 
mto2 cells, and results in a decoration of MTs and the NE by Mto1. However, concurrent 
over-expression of Mto1 and Mto2 is required to achieve similar decoration of MTOCs by 
Mto2 (Samejima et al., 2005). Overall, these observations indicate that Mto2 function is 
mediated by Mto1.  While Mto1 is the principle factor in determining -TuC localization, 
Mto2 appears to have a specific role in interphase MT nucleation from non-SPB sites.  
 Mto1 is a paralog of Pcp1, and contains a CM1 domain as well as a distinct Mto2-
binding region, in addition to extensive predicted coiled-coils (Samejima et al., 2005; 
Samejima et al., 2008). Deletion of residues within the Mto2-binding region disrupts the 
Mto1-Mto2 interaction, and results in a phenotype that mimics mto2 with respect to 
Mto1 localization, -TuC localization, and MT nucleation (Samejima et al., 2008). Mutations 
in the CM1 domain, in which  stretches of 9 amino acids are replaced with alanine, 
eliminate interaction between Mto1 and the -TuC. This does not affect Mto1 localization, 
but does abolish cytoplasmic MT nucleation, and results in a lack of -TuC localization to 
cytoplasmic MTOCs (Samejima et al., 2008). However, unlike the CDK5RAP2 CM1 region, 
the Mto1 CM1 domain alone is insufficient for association with the -TuC. In fact, both the 
CM1 domain and Mto2-binding regions must be present on the same Mto1 molecule in 
order for both Mto1 and Mto2 to associate with the -TuC, suggesting a cooperativity in 
binding (Samejima et al., 2008). Indeed, both Mto1 and Mto2 show little or no association 
with the -TuC in the absence of the other protein. In addition, the Mto1-Mto2 interaction 
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is preserved under high salt conditions that disrupt the Mto1/2--TuC interaction. Coupled 
with the observation that Mto1 and Mto2 interact in mto1 CM1 mutants, this suggests that 
Mto1 and Mto2 form a subcomplex that assembles independent of -TuC proteins 
(Samejima et al., 2008).  
 Mto1 also contains a conserved sequence of roughly 44 amino acids in its C-
terminus, which is present in the C-terminus of a single protein in a variety of fungal species 
(Samejima et al., 2010). Like Mto1, many of these proteins contain a CM1 motif and are 
predicted to contain  extensive regions of coiled-coil. Amongst these proteins, the most 
distantly related C-terminal motif is present in Spc72, which lacks a CM1 domain. However, 
given the analogous functions of Mto1 and Spc72 in mediating cytoplasmic MT nucleation 
from the SPB, this sequence is referred to as MASC (Mto1 and Spc72 C terminus)(Samejima 
et al., 2010).  
 The Mto1 MASC region, as well as an adjacent stretch of ~20 amino acids, is 
required for targeting Mto1 to MTOCs, and thus regulates Mto1/2 complex and -TuC 
localization in the cytoplasm (Samejima et al., 2010). The MASC sequence is remarkably 
modular, containing distinct sequences that mediate localization to the eMTOC, interphase 
SPB (iSPB), and mitotic SPBs (mSPBs). However, expression of GFP-tagged Mto1 fragments 
reveals that the MASC sequence alone does not localize to prospective MTOCs. In order to 
localize effectively, MASC-containing fragments of Mto1 must be multimerized, either by 
inclusion of Mto1 coiled-coil sequence or by fusion with heterologous coiled-coil sequences 
(Samejima et al., 2010). 
 MASC-dependent localization of Mto1 to the eMTOC, and by extension PAA 
nucleation, depends on the non-essential type II myosin Myp2 (Samejima et al., 2010). 
Myp2 localizes to the contractile actin ring but is only required for cytokinesis under stress 
conditions, such as nutrient starvation or high salt (Bezanilla et al., 1997; Motegi et al., 
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1997). Co-immunoprecipitation and yeast two-hybrid assays strongly suggest that Mto1 
interacts directly with Myp2 (Samejima et al., 2010), and this interaction may account for 
the dependence of PAA nucleation on actin ring formation (Pardo and Nurse, 2003).  
Further, localization of Mto1 to mSPBs requires Sid4 and Cdc11, both of which are present 
at SPBs and involved in recruiting proteins related to septation (Samejima et al., 2010). 
Nonetheless, the receptors which directly mediate Mto1 attachment to SPBs remain to be 
determined.  
 Unlike Mto1, The fission yeast homologues of GCPs 4, 5, and 6 (Gfh1, Mod21, and 
Alp16) are dispensable for both interphase and mitotic MT nucleation. Individual or 
simultaneous deletion of all three proteins produces no qualitative change in MT 
organization, but does result in a quantitative reduction in the frequency of interphase MT 
nucleation and number of interphase MT bundles (Anders et al., 2006). Simultaneous 
deletion of GCPs 4-6 has no additive effect relative to single deletions, suggesting that these 
proteins have redundant roles in MT nucleation. GCPs 4-6 are also co-dependent for 
association with -TuSC proteins, which may account for the lack of an additive phenotype 
in the triple deletion mutant (Anders et al., 2006).  These observations imply that -TuSCs, 
in  association with Pcp1 or the Mto1/2 complex, may be sufficient for promoting MT 
assembly. Notably, -TuRC ring structures have not been directly identified in fission yeast,  
and sucrose gradient analysis indicates that the vast majority of fission yeast -TuCs are 
present as small complexes (Anders et al., 2006). However, GCPs 4-6 co-localize with -TuSC 
components at all MTOCs, suggesting that -TuRCs are indeed present in S. pombe (Anders 











 Overall, current evidence suggests that the -TuC alone is not sufficient for MT 
nucleation. Additional factors present at MTOCs  may be necessary for activating MT 
nucleation by the -TuC. However, with the exception of CDK5RAP2, activators of the -TuC 
remain to be identified.  In the present work, I seek to address whether or not the Mto1/2 
complex contributes directly to -TuC activation.  
 We know that the Mto1/2 complex is required for localization of the -TuC to 
cytoplasmic MTOCs, and also for cytoplasmic MT nucleation. This allows us to envisage two 
general models for Mto1/2 function: Mto1/2 could be responsible only for localizing the -
TuC to MTOCs, where the -TuC is then activated by other proteins. Alternatively, Mto1/2 
could be responsible for both localizing and activating the -TuC. To address these 
possibilities, I aimed to generate a mutant of the Mto1/2 complex that failed to localize to 
conventional MTOCs — if a non-localizing version of Mto1/2 were still able to promote MT 
nucleation from the -TuC, this would provide evidence that Mto1/2 is a -TuC activator. To 
truly prove that Mto1/2 is a -TuC activator, however, will require in vitro reconstitution of 
a complex that is capable of robust MT nucleation. Towards this more long-term objective, I 
aimed to express, purify, and characterize recombinant Mto1/2 complex produced using a 



















2. Materials and Methods 
 
2.1 Growth of fission yeast strains 
 
Fission yeast were grown in rich yeast extract medium (YE5S) or Edinburgh minimal 
medium (EMM) with the following compositions: 
 
YE5S: 0.5% (w/v) Difco Yeast Extract, 3.0% (w/v) glucose, 250 mg/L each of adenine, 
histidine, leucine, lysine  hydrochloride, and uracil.  
EMM:  14.7 mM potassium hydrogen phthalate, 15.5 mM Na2HPO4, 2% glucose, 1X salts 
(50X salt stock solution: 52.5 g/L MgCl2•6H2O, 0.735 mg/L CaCl2•2H2O, 50 g/L KCl, 2 g/L 
Na2SO4), 1X vitamins (1000X vitamin stock: 1 g/L pantothenic acid, 10 g/L nicotinic acid, 10 
mg/L biotin), 1X minerals (10,000X mineral stock: 5 g/L boric acid, 4 g/L MnSO4, 4 g/L 
ZnSO4.7H2O, 2 g/L FeCl2.6H2O, 0.4 g/L molybdic acid, 1 g/L KI, 0.4 g/L CuSO4.5H2O, 10 g/L 
citric acid), and 2.2 g/L NH4Cl or 3.75 g/L L-glutamic acid monosodium salt. Amino acid 
supplements are added as required (200 mg/L).  
 
2% Difco Bacto agar was added for growth on solid plates. G418 (Geneticin), nourseothricin 
(ClonNat), and hygromycin were added at 100 g/ml when required for selection. YE5S + 5 
mg/L Phloxin B was used to check for dead and diploid cells, which take up Phloxin B more 
readily than living/haploid cells and thus show dark pink staining.  
 
Strains were stored at -80oC in YE5S + 25% Glycerol.  
 
 
2.2 Genetic crosses 
 
Fission yeast mating was performed on SPA plates [2% Difco Bacto agar, 30 g/L 
glucose, 5 g/L KH2PO4, amino acid supplements and 1X vitamins (as for EMM)]. h- and h+ 
strains to be mated were streaked onto SPA, mixed with a small volume (eg. 10 l) of 
distilled water, and placed at 25oC or 28oC for 2X overnight to form asci. Asci from the 
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mating plate were streaked onto YE5S and placed at 32oC for approximately 30-60 minutes 
to allow for ascus wall breakdown. Spores from individual tetrads were then dissected 
using a Singer dissection microscope and placed at 32oC to germinate and form colonies. 
Once colonies reached a suitable size (1-2 mm diameter, typically after 2-3 days), they were 
replica-plated to phloxin B plates and also to appropriate selective media in order to 
identify genotypes.  
 
 
2.3 PCR amplification of DNA 
 
Polymerase chain reaction (PCR) amplification of DNA was performed using a MJ 
Research Thermal Cycler. Reactions were performed using either Phusion High-Fidelity DNA 
Polymerase (Thermo Scientific) or a combination of Pwo and homemade Taq (HMT) 
polymerases.  The following reaction and cycling conditions were used: 
 
Pwo/HMT Polymerase PCR: 
Component Concentration 
*Buffer IV 1X 
Forward primer 0.2 M 
Reverser primer 0.2 M 
Template DNA  1 ng/l 
dNTPs (dATP, dTTP, dGTP, dCTP) 500 M each  
MgCl2 3.5 mM 
HMT polymerase 0.2 U/l 
Pwo polymerase 0.003 U/l 
 
*10X buffer IV contains 750 mM Tris-HCl pH 8.8, 200 mM (NH4)2SO4, 0.1% Tween 20.  
When using Pwo/HMT polymerase, annealing temperature was first optimized by 
performing gradient PCR over a range of annealing temperatures. Subsequent amplification 






1. 95oC 2 min 
2. 95oC 15 sec 
3. 50-70oC 30 sec 
4. 72oC 6 min 
5. Repeat steps 2-4 for 30 cycles 
6. 72oC 5 min 
7. 20oC hold 
 
 
Phusion Polymerase PCR: 
Component Concentration 
HF Buffer 1X 
Forward primer 0.5 M 
Reverser primer 0.5 M 
Template DNA (plasmid) 1 ng/l 
dNTPs (dATP, dTTP, dGTP, dCTP) 200 M each 
Phusion polymerase 0.02 U/l 
 
Temperature cycle: 
1. 98oC 2 min 
2. 98oC 15 sec 
3. 60oC 30 sec 
4. 72oC 3 min 
5. Repeat steps 2-4 for 30-35 cycles 
6. 72oC 10 min 
7. 20 oC hold 
 
Product yields were determined by subjecting samples to electrophoresis on 1% agarose 
gels in TAE buffer (40 mM Tris Base, 0.1% glacial acetic acid, 1 mM EDTA) with 0.5 g/ml 
ethidium bromide. Samples were prepared in 1X orange G buffer (6X stock: 0.05% Orange 
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G, 5% Glycerol). Gels were run at ~100V and visualized by UV illumination. A 1kb or 100 bp 
ladder (New England Biolabs) was used for size standards.  
 
 
2.4 Strain construction using the PCR-based method 
 
Truncation and tagging of fission yeast genes was performed using the PCR-based 
methods described by Bahler et al., 1998. Primers were designed with 5’ ends containing 
about 80 nucleotides of homology targeted to the genomic sequence of interest. 3’ ends of 
primers contained 20-22 nucleotides of homology to tagging cassettes, and were used to 
amplify sequences encoding antibiotic resistance   (G418, hygromycin, nourseothricin), nmt 
promoters, and/or GFP tags. Homologous integration of these PCR products into fission 
yeast strains was used to generate N- and C-terminal truncation mutants with or without 
GFP tags. The same approach was used for tagging genes at their full-length C-termini. N-
terminal truncations produced using this method were placed under control of the 
thiamine-repressible nmt81 promoter.  
DNA amplification for tagging/truncation was performed by PCR using Pwo/HMT or 
Phusion polymerase, as described above. Approximately 20-30 g of DNA was produced for 
each transformation (1 mL PCR reactions routinely yielded 50-100 g of the desired 
product). Prior to transformation, PCR products were cleaned-up using 
phenol/chloroform/isoamyl alcohol (PCI) extraction. An equal volume of PCI was added to 
PCR reactions, which were then vortexed and spun at max speed (13000 RPM) for 5 
minutes in a microfuge. The supernatant was then recovered and transferred to a fresh 
tube. PCI extraction was then repeated, and the supernatant recovered again. Chloroform 
was then added to remove remaining PCI, and samples were vortexed and spun for 5 
minutes. NaOAc (pH 5.2) was added to the supernatant at a final concentration of 0.3M, 
followed by 2 volumes of ethanol (to precipitate DNA). Samples were mixed at RT for ~5 
minutes, and spun in a microfuge for 10 minutes at 4oC. DNA pellets were washed with 70% 
ethanol, dried, and resuspended in 50 l of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). 




PCI-clean DNA was then transformed into a fission yeast parent strain. Cells were 
grown overnight at 30oC in YE5S to an OD of approximately 0.8. 20 mL of cells was spun at 
4000 RPM for 5 minutes, washed with an equal volume of dH2O, spun again, and washed 
with 1 mL of 0.1M LiOAc/TE (pH 7.5). Cells were spun again and resuspended in LiOAc/TE to 
a final volume of 100 l. PCI-clean DNA (20-30 g) was added to the cell suspension and left 
to incubate for 10 minutes at RT. 260 l of 40% PEG in LiOAc was then added with gentle 
mixing, and cells were incubated at 32oC for 45 minutes. 43 L of DMSO was then added, 
and cells were heat-shocked at 42oC for 5 minutes. Cells were then washed with 1 mL of 
dH2O, plated onto 2X YE5S plates, and placed at 32
oC. The following day, cells were replica-
plated to YE5S containing G418, hygromycin, or nourseothricin, as required for selection. 
After 2 more days at 32oC, cells were again replica-plated to selective media (YE5S with the 
appropriate antibiotic). On the following day, single colonies were then streaked onto YE5S, 
grown ON, and replica-plated to selective media to check for stably integrated 
transformants. Stable integrants were identified as isolates where every colony that formed 
on YE5S also grew on selective media. A combination of colony PCR, Western blotting, and 
fluorescence microscopy was used to confirm successful generation of the desired strain. 
Strains constructed using the PCR-based method are shown in table 2.1.  
 
Table 2.1: Oligonucleotides, plasmids and parent strains used to generate truncated and/or tagged 
mutants using the PCR-based method.  
 
Strain Primers (Forward/reverse) Plasmid Parent strain 
KS5207 OKS459 / OKS462 pKS112 KS516 
KS5209 OKS1927 / OKS462 pKS112 KS516 
KS5211 OKS1928 / OKS462 pKS112 KS516 
KS5213 OKS1929 / OKS462 pKS112 KS516 
KS5215 OKS1930 / OKS462 pKS112 KS516 
KS5217 OKS1931 / OKS462 pKS112 KS516 
KS5381 OKS444 / OKS449 pKS706 KS820 
KS5385 OKS444 / OKS449 pKS706 KS5209 
KS5517 OKS444 / OKS1981 pKS706 KS5209 
KS5520 OKS444 / OKS1983 pKS706 KS5209 
KS5607 OKS2034 / OKS462 pKS108 KS515 
KS5647 OKS444 / OKS345 pKS706 KS5209 
KS5749 OKS1927 / OKS462 pKS112 KS2007 
KS5817 OKS2077 / OKS2088 pKS131 KS516 
KS5826 OKS460 / OKS2055 pKS112 KS516 
KS5922 OKS1927 / OKS2055 pKS112 KS5851 
KS5924 OKS1927 / OKS2055 pKS112 KS5853 
KS5926 OKS1927 / OKS2055 pKS112 KS5855 
KS5940 OKS2106 / OKS2055 pKS112 KS5851 
KS6626 OKS2034 / OKS462 pKS108 KS5851 
KS6682 OKS2286 / OKS2287 pKS112 KS516 
KS6684 OKS2284 / OKS2285 pKS112 KS516 
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2.5 Colony PCR 
 
Colony PCR was used to verify integration of transformed DNA at the correct locus. 
Amplification was performed using a primer with homology to the integrated antibiotic 
marker coupled with a primer homologous to sequence upstream of the target gene (for N-
terminal tagging/truncation) or downstream of the gene (for C-terminal 
tagging/truncation). The generation of a PCR product of the correct predicted size was 
taken as confirmation that integration had occurred. To produce template DNA, cells to be 
analyzed were grown overnight on YE5S plates. A small patch (1-2 mm) of cells was 
resuspended in 50 l of 0.25% SDS in TE, vortexed, and boiled for 5 minutes.  Boiled 
samples were spun for 1 min at 13000 RPM, and the supernatant containing template DNA 




Colony PCR reaction mixtures 
Component Concentration 
*Buffer IV 1X 
Forward primer 0.5 M 
Reverser primer 0.5 M 
Template DNA  2 l / 25 l reaction 
dNTPs (dATP, dTTP, dGTP, dCTP) 200 M each  
MgCl2 1.5 mM 
HMT polymerase 0.2 U/l 
Pwo polymerase 0.003 U/l 










1. 95oC 2 min 
2. 95oC 15 sec 
3. 50oC 30 sec 
4. 72oC 3 min 
5. Repeat steps 2-4 for 35 cycles 
6. 72oC 5 min 
7. 20 oC hold 
 
 
2.6 Fission yeast boiled extracts 
 
Boiled extracts were used for Western blot analysis of fission yeast proteins, 
primarily to check expression levels of Mto1 truncation mutants. To produce boiled 
extracts, cells were grown overnight to an OD of ~0.8. Cells were typically grown in YE5S, 
but EMM supplemented with adenine, leucine, and uracil was used when expression from 
the nmt81 promoter was required. 25 mL of cells was spun at 4000 RPM for 3 minutes, and 
the cell pellet was then resuspended in 1 mL of TBS (Tris-buffered saline; 50 mM Tris base, 
150 mM NaCl, pH 7.6). Samples were then spun for 1 minute at 13000 RPM in a microfuge. 
The supernatant was poured off, and the pellet was resuspended in the small remaining 
volume by vortexing. The pellet was then boiled for 5 minutes to inactivate any proteases. 
0.5 mm zirconium beads were added and the samples were beat in a Ribolyser (2 cycles of 
30 seconds at maximum speed). The bottoms of the tubes were pierced and placed into a 
second tube, and lysates were recovered by briefly centrifuging at 1000 RPM. 200 L of TBS 
and 200 L of 2X Laemmli sample buffer (4% SDS, 20% glycerol, 120 mM Tris-HCl, pH 6.8) 
were added to the flow-through. Samples were then boiled for 5 minutes, spun at 13000 
RPM for 15 minutes, and the supernatant (boiled extract) was recovered.  
Protein concentration in boiled extracts was determined by Bicinchoninic acid 
(BCA) assay. Reaction mixture was prepared by combining BCA reagent A (containing 
Bicinchoninic acid) and BCA reagent B (containing 4% copper (II) sulphate) at a 50:1 ration. 
5 l of boiled extract was added to 1 mL of BCA reagent mixture, incubated at 65oC for 15 
minutes, and then immediately placed on ice. OD (562 nm) was then determined using a 
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spectrophotometer. Protein concentration was calculated based on previous calibration 
(not shown), which revealed that 1 g/mL of protein yields an OD (562 nm) of 0.04. Boiled 
extracts were stored at -80C. Prior to running on SDS-PAGE, bromophenol blue (~0.01%) 
and DTT (0.1M) or -mercaptoethanol (2.5%) were added to samples.  
 
 
2.7 SDS-PAGE, coomassie staining and Western blotting 
 
 All sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed with 5% acrylamide stacking gels and 10% acrylamide resolving gels in Laemmli 
running buffer (25 mM Tris-base, 192 mM glycine, 0.1% SDS, pH 8.3). Gels were cast using 
the Mini-Protean (BioRad) or "low-wide" 10 x 20 cm  (Helena Biosciences) system. Protein 
samples were prepared in Laemmli sample buffer (2% SDS, 10% glycerol, 60 mM Tris-HCl pH 
6.8, 0.01% bromophenol blue, 0.1M DTT or 2.5% -mercaptoethanol), boiled, allowed to 
cool, and spun briefly in a microfuge before loading onto gels. Mini gels and low-wide gels 
were run at 30 mA and 70 mA per gel, respectively.  
 For coomassie staining, gels were transferred to staining solution (25% isopropanol, 
10% acetic acid, 0.05% Brilliant Blue R-250) immediately after electrophoresis. Gels in 
staining solution were heated briefly (~30 sec) in a microwave on high setting and placed on 
a shaker for 10-15 minutes.  Staining solution was replaced with destaining solution (10% 
acetic acid) and the gel was again heated in the microwave. Gels were left in destaining 
solution until sufficiently clear, and destaining solution was replaced if necessary.  
 For anti-Mto1 and anti-Mto2 Western blotting, proteins were transferred to 
nitrocellulose membrane (BioRad) in 10 mM CAPS and 10% methanol using a wet blotting 
apparatus. Mini gels were transferred for 80 minutes at 80V, and low-wide gels were 
transferred for 150 minutes at 40V. Efficient transfer of proteins was confirmed by briefly 
staining with Ponceau S (0.2% Ponceau S, 3% trichloroacetic acid, 3% sulfosalicylic acid), 
followed by gentle destaining in 5% acetic acid. Ponceau stain was removed by washing in 
water followed by TBS. Membranes were then placed in blocking solution (2% non-fat dried 
milk, 0.2% Tween 20 in TBS) for 30 minutes. Incubation with primary antibodies was 
performed overnight in blocking solution. Anti-Mto1 (S897, polyclonal raised in sheep) and 
anti-Mto2 (S975, polyclonal raised in sheep) primary antibodies were used at 1:1000 
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dilutions of serum. Membranes were then washed (0.02% Tween 20 in TBS) and incubated 
with secondary monoclonal mouse anti-sheep IgG for 1 hour (Sigma-Aldrich; 1:10000 in 
blocking solution).  Finally, membranes were washed again and incubated in tertiary anti-
mouse IRDye800 fluorescent antibodies for 1 hour (Licor Bioscience; 1:5000 in blocking 
solution).  For more highly expressed recombinant proteins from Sf9 cells, only primary 
anti-Mto1 or anti-Mto2 antibodies with secondary anti-goat IRDye800 fluorescent 
antibodies (Licor Bioscience; 1:5000 in blocking solution) were used. An Odyssey scanner 
and associated software (Licor Odyssey v3.0) was used to visualize and quantify bands. For 
quantification, a rectangular region was drawn around the band of interest, and the 
integrated fluorescence intensity within that region was determined. Background was 
subtracted as the integrated intensity of a band of equal size, taken from a representative 
region of the blot lacking bands.  
 
 
2.8 Endogenously expressed mto1 N-terminal truncations 
 
A two-step gene replacement technique was used to generate Mto1 N-terminal 
truncations expressed from the endogenous mto1 promoter. In the first step, mto1 
nucleotides 1-390 (amino acids 1-130) in KS516 were replaced with the ura4+ sequence, 
using the techniques described in section 2.4.  Selection was performed on EMM 
supplemented with adenine and leucine, but lacking uracil. Stable mto11-130)::ura4+ 
integrants were identified by colony PCR. In the second step, megaprimer PCR was used to 
produce 567 base pair fragments of mto1, where the mto1 start codon was immediately 
adjacent to mto1 nucleotide 391, 607, or 724 (corresponding to amino acids 131, 203, and 
242). Transformation of megaprimer products into mto11-130)::ura4+ was thus used to 
produce mto1(131-1115), mto1(203-1115), and mto1(242-1115) strains. Transformants were 
counter-selected by plating onto 5-fluoroorotic acid (5-FOA) plates (EMM + Na glutamate, 
leucine, adenine, ¼ uracil, 0.1% FOA). 5-FOA is converted to the toxic product 5-fluorouracil 
by the ura4 gene product orotidine 5'-phosphate decarboxylase, leading to killing of the 
ura4+ parent strain. Successful construction of mto1(131-1115), mto1(203-1115), and 
mto1(242-1115) was confirmed by DNA sequencing. The standard Bähler cassette method 
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was subsequently used to produce endogenously-expressed mto1(131-549), mto1(131-
549)-GFP, mto1(203-549)-GFP, and mto1(242-549)-GFP.  
Megaprimer PCR was itself a 2-step process. In the first step, pairs of PCR reactions 
were used to amplify regions of mto1 sequence. One reaction amplified approximately 280 
base pairs of mto1 5' upstream sequence, followed by about 15 base pairs of mto1 coding 
sequence starting at the desired N-terminal truncation site. The second reaction amplified 
about 15 base pairs of mto1 5' upstream sequence, followed by about 280 base pairs of 
mto1 coding sequence starting at the desired N-terminal truncation site. Therefore, the 
products of these two reactions contained an approximately 30 base pair overlap. These 
products were then gel purified, in order to remove primers. In the second step, the gel-
purified products were amplified by overlap extension PCR (ie. the first step products acted 
as “megaprimers”). Products from the second step were cleaned-up by PCI extraction prior 
to transformation into mto11-130)::ura4+ (KS5817).  
 
Table 2.2: Oligonucleotides used for construction of endogenously expressed Mto1 N-
terminal truncation mutants. Mutants were produced by 2-step megaprimer PCR. pKS272 
was the template in all step 1 reactions. Step 2 PCR products were transformed into the 
KS5817 ura4+ parent strain.   
Strain 
Step 1 Step 2 




1 OKS2079 / OKS2080 Products of 1 
and 2  
OKS2079 / OKS2090 
2 OKS2081 / OKS2090 
KS5853 
3 OKS2079 / OKS2083 Products of 3 
and 4 
OKS2079 / OKS2089 
4 OKS2084 / OKS2089  
KS5855 
5 OKS2079 / OKS2085 Products of 5 
and 6  
OKS2079 / OKS2082 
6 OKS2086 / OKS2082 
 
2.9 DNA sequencing 
 
For sequencing of fission yeast mutants, colony PCR followed by gel purification 
was first performed to generate template DNA containing the region of interest. Plasmid 
DNA was sequenced directly. Sequencing reactions were prepared as follows: 2 l BigDye 
3.1 terminator mix (Applied Biosystems), 2.5 l 5X sequencing buffer (Applied Biosystems), 
2 l oligonucleotide primer (at 3 M in TE buffer), and 6 l template DNA (PCR product or 





1. 96oC 30 sec 
2. 50oC 15 sec 
3. 60oC 4 min 
4. Repeat steps 1-3 for 25 cycles 
5. 4oC hold 
 
Reactions were then sequenced by the University of Edinburgh GenePool sequencing 
service, using ABI 3730 capillary sequencing instruments. Sequencing data was analyzed 





Wide-field microscopy was performed using a Nikon TE300 inverted microscope 
with a Nikon 100x/1.40 NA Plan Apo or Nikon 20X/0.75 NA Plan Apo objective, attached to 
a Photometrics Coolsnap HQ CCD camera. Confocal microscopy was performed using a 
Nikon TE2000 inverted microscope with a Nikon 100x/1.45 NA Plan Apo objective, attached 
to a Yokogawa CSU-10 spinning disc confocal unit (Visitech) and an Andor iXon+ Du888 
EMCCD camera. An Optosplit III image splitter (Cairn Research) with a T560LPXR dichroic 
filter (Chroma Technology) was used for simultaneous imaging of GFP- and RFP-tagged 
proteins. The Optosplit III was used in co-imaging GFP-tagged Mto1/2 and -TuC proteins 
with mCherry--tubulin, and also for imaging the colocalization of Mto1-GFP and Alp4-tDT. 
Where they are compared directly, all still and time-lapse images were acquired under 
identical conditions. Image processing was performed using Metamorph imaging software 
(Molecular Devices). Images were adjusted using linear contrast enhancement and are 
presented as maximum projections through the full cell volume, unless otherwise indicated. 
For live-cell microscopy, cells were grown 2-3 days overnight in EMM at 25oC. Cultures were 
diluted daily to maintain exponential growth. Before imaging, cells were pipetted onto pads 
(~50 m thick) composed of EMM with 2% agarose. A coverslip was placed on top of the 
cells, and the coverslip edges were sealed with VALAP (33% Vaseline, 33% lanolin, 33% 
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paraffin). Imaging was performed at room temperature. The conditions used for 
fluorescence microscopy are shown in table 2.3.  
 
Table 2.3 Conditions used for fluorescence microscopy.  
Image type Figures 
Laser power (%), 
exposure time (ms) Z series  Timelapse 
488 nm 561 nm 
Mto1-GFP  3.3A, 4.3, 
5.1 
70, 500 - 9 x 0.6m - 
Mto1-GFP, mCh--
tubulin 
3.3B 70, 500 40, 500 9 x 0.6m - 




3.6, 4.6 70, 500 40, 500 9 x 0.6m - 
Mto1-GFP, Alp4-tdT * 3.7, 4.8 50, 2000 40, 2000 8 x 0.6m - 
GFP--tubulin  3.9, 4.9, 
4.10A, 5.2A, 
5.2C, 5.5A 
20, 100 - 9 x 0.5m 100 x 5s 
Over-expressed Mto1-
GFP 
4.2 80, 500 - 9 x 0.6m - 
Mto1-GFP in MBC 4.4 70, 800 - 8 x 0.6m - 
Nucleating puncta (GFP 
tag), mCh--tubulin * 
4.12, 4.13A 70, 200 70, 200  8 x 0.6m 80 x 1.63s  
Rlc1-GFP nodes * 4.13B 70, 200 70, 200  12 x 0.6m - 
Plo1-GFP * 4.13B 70, 200 70, 200  12 x 0.6m - 
Mto2-GFP, mCh--
tubulin * 
5.3 70, 200 70, 200 8 x 0.6m 40 x 1.63s 
* Imaged with Optosplit III image splitter (simultaneous illumination by 488 nm and 561 nm    
lasers).  
 
Fluorescence quantification of nucleating puncta: 
 
Fluorescence quantification was used to determine the copy numbers of Mto1-
bonsai-GFP, Mto2-GFP, Alp4-GFP, and Alp6-GFP in puncta associated with microtubule 
nucleation. The intensities of nucleating puncta were measured, and converted into copy 
numbers by comparison to a standard imaged under the same conditions. The average 
intensity of Rlc1-GFP nodes, which contain on average 41.3 ± 23 molecules of Rlc1 (Laporte 
et al., 2011), was determined and used as the calibration standard. Plo1-GFP at recently 
separated SPBs was imaged and quantified during each imaging session, in order to verify 
that consistent values of intensty/GFP molecule were observed. Each protein was tagged 
with the same version of GFP [GFP(S65T)], to allow for direct comparison of fluorescence 
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intensity. Identical illumination conditions were used to image nucleating puncta, Rlc1-GFP, 
and Plo1-GFP, although nucleating puncta were imaged by time-lapse with fewer Z-sections 
(Table 2.3). When imaging nucleating puncta, only a single movie was made per slide, in 
order to minimize photobleaching. Movies with significant photobleaching were discarded, 
and little or no bleaching was observed in the movies used for quantification (Figure 2.1) 
 Fluorescence intensity was measured using Metamorph imaging software. 
Nucleating puncta were quantified at the onset of microtubule nucleation. 2 Z-sections 
containing the punctum of interest were summed, and the total intensity in a 5x5 pixel 
circular region around the punctum was determined. The intensities of 3 adjacent regions 
of the same size were averaged to provide a background value, which was then subtracted 
to produce the final intensity measurement. The intensities of Rlc1-GFP nodes were 
determined in the same manner, except 4 adjacent regions were averaged to produce a 
background value. Plo1-GFP intensity at SPBs was quantified in sum projections of 8 Z-
sections using a 10x10 pixel circular region. For Plo1-GFP, the intensity of a single adjacent 





2.11 Morphology assays 
 
To analyze cell morphology, cells were grown to stationary phase to cause partial 
depolarization, and then allowed to regrow in fresh YE5S to reveal any polarity phenotypes. 
Cells were patched uniformly onto YE5S plates, and allowed to grow for 2-3 days. Cells were 
then replica-plated to fresh YE5S and allowed to grow for 3 hours, after which they were 
washed from plates using PBS (Phosphate Buffered Saline; 1.5 mM KH2PO4, 5.1 mM 
Na2HPO4, 150 mM NaCl, pH 7.4) and fixed in 3.7% formalin for 30 minutes. Fixed cells were 
washed in PBS to remove excess formalin and imaged by wide-field DIC microscopy with a 
20X objective.  
 
 
2.12 Cold-shock and MT regrowth  
 
Cells for cold-shock and MT regrowth experiments were grown in EMM at 30oC to 
an OD of 0.8. MTs were depolymerized by chilling cells in flasks in an ice-water slurry for 30 
minutes. MT regrowth was allowed to occur by returning flasks to a water bath at 25oC. 
Cells were harvested by suction filtration and fixed in -80oC methanol at various timepoints 
(Pre cold-shock and 0, 1, 3, and 10 minutes following return to 25oC). Methanol-fixed cells 
were then processed for anti-tubulin immunofluorescence. Cells were pelleted and washed 
2X in PEM buffer (100 mM NaPIPES pH 6.8, 1 mM MgCl2, 1 mM EGTA), resuspended in 
PEMS (PEM + 1M sorbitol) containing 1 mg/mL zymolysase, and digested for 30 minutes at 
37oC. Following digestion, cells were washed 2X in PEMS and incubated in PEMS + 1% Triton 
X-100 for 30 seconds. Cells were again washed 2X in PEM before being resuspended in 
PEMBAL blocking solution (PEM + BSA, NaN3, lysine monohydrochloride) for 3 hours. For 
anti-tubulin immunofluorescence, cells were then pelleted and resuspended in PEMBAL 
containing TAT1 anti-tubulin antibody (mouse monoclonal, used at 1:40 dilution) and 
incubated overnight. Following 3X 2 hour washes in PEMBAL, cells were incubated 
overnight in secondary antibodies. Alexa 568 labelled goat-anti-mouse IgG (Molecular 
Probes Europe BV) was used as the secondary antibody (1:100 dilution in PEMBAL). Finally, 
cells were washed 3X 2 hours in PEMBAL. For imaging by wide-field fluorescence 
microscopy, cells were spun onto coverslips pre-coated with poly-L-lysine (10 mg/mL).  
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2.13 Measurement of nuclear positioning 
 
For staining of nuclei, cells were grown 3X overnight in EMM at 25oC. 0.5 mL of cells 
from an exponential culture was spun briefly in a microfuge at 5000 RPM, washed in dH2O, 
and resuspended to a final volume of 10 l in dH2O.  Cells were fixed by heat denaturation 
by pipetting them onto a coverslip on a 65oC heating block and allowing water to 
evaporate. 2.5 l of mounting media containing Hoecsht DAPI stain was added to fixed 
cells. Bright-field images of whole cells and fluorescent images of stained nuclei were then 
obtained using a wide-field microscope. The distance from the centre of the nucleus to the 
nearest cell tip (S) and the furthest cell tip (L) was measured using ImageJ image analysis 
software. Nuclear eccentricity was reported as the ratio S/L (ie. where a perfectly centred 
nucleus would have an S/L = 1).  
 
2.14 Imaging of Mto1 in the presence of MBC 
 
Cells imaged in the presence of methyl benzimidazol-2-yl-carbamate (carbendazim, 
MBC) were initially grown under standard conditions (EMM, 25oC). A 5 mg/mL stock 
solution of MBC in DMSO was prepared, and MBC stock solution was added to aliquots of 
cells at a 1:100 dilution (giving 50 g/ml MBC final). MBC was also added to EMM/agar pads 
used for imaging, at the same concentration. Cells were left to incubate in MBC for 10-15 
minutes prior to imaging on a confocal microscope, and were imaged no later than 45 
minutes after addition of MBC. As a control, the same strains were treated with DMSO 
alone and imaged under identical conditions.  
 
2.15 Growth of E. coli strains 
 
All Escherichia coli (E. coli) strains were grown at 37oC in liquid LB media (10 g/L 
Difco Bacto tryptone, 5 g/L Difco Bacto yeast extract, 5 g/L NaCl, pH 7.2) or on solid LB-agar 
plates (LB + 2% Difco Bacto agar). TOP10 (Invitrogen) or DH5 E. coli strains were used 
throughout for cloning and amplification of plasmids. Antibiotics were added to media as 
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required at the following concentrations: ampicillin (100 g/mL), tetracycline (10 g/mL), 
gentamicin (7 g/mL), and kanamycin (50 g/mL).  
 
 
2.16 Production of chemically competent E. coli 
  
 Chemically competent E. coli cells were generated using the Rubidium Chloride 
method. A single E. coli colony was used to inoculate 5 mL of LB and grown overnight at 
37oC. The culture was then diluted 1:200 into 100 mL of LB containing 20 mM MgSO4 and 
allowed to grow at 37oC until an OD(600 nm) of approximately 0.5 was reached. Cells were 
then chilled on ice for 10 minutes, and pelleted by centrifugation for 5 minutes at 5000 
RPM and 4oC. Media was decanted and cells were resuspended in 40 mL of cold TFB1 buffer 
(30 mM KAc, 100 mM RbCl2, 10 mM CaCl2, 50 mM MnCl2, 15% glycerol, pH to 5.8 with 
HOAc, filter sterilized) and incubated on ice for 5 minutes. Cells were again pelleted at 4oC, 
then resuspended in 4 mL of TFB2 buffer (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl2, 15% 
glycerol, pH 6.5 with KOH, filter sterilized) and incubated on ice for 15 minutes. 200 L 
aliquots of competent cells were then transferred to -80oC for storage.  
 
 
2.17 Transformation of E. coli 
 
 About 50-100 ng of DNA was typically used for transformation of ~50 L of 
chemically competent E. coli. An aliquot of chemically competent cells was thawed on ice, 
DNA was added, and cells were left to incubate on ice for 30 minutes. Cells were then heat-
shocked for 60 seconds at 42oC, returned to ice, and 450 mL of SOC media (20 g/L Difco 
Bacto tryptone, 5 g/L Difco Bacto yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4, 20 mM glucose) was added. Cells were then allowed to recover in SOC at 37
oC 
for 1 hour, before being plate to LB-agar (containing appropriate antibiotics for plasmid 





2.18 Isolation of plasmid DNA from E. coli 
 
 Plasmid DNA was extracted from E. coli using the Zyppy Plasmid Miniprep Kit (Zymo 
Research). E. coli cultures for plasmid miniprep were grown ON at 37oC in LB containing 
appropriate antibiotics. 100 L of 7X Lysis Buffer was added to 600 L of bacterial culture, 
and lysis was allowed to proceed for 1-2 minutes. 350 L of cold Neutralization Buffer 
(containing 100 g/mL RNase A) was then added with mixing. Cell debris was pelleted by 
centrifuging at 13000 RPM for 4 minutes, and the supernatant containing plasmid DNA was 
then transferred to a Zymo-Spin IIN column. The column was washed with 200 L of Endo-
Wash Buffer followed by 400 L of Zyppy Wash Buffer. DNA was then eluted using 30-50 L 
of Zyppy Elution Buffer. Where more plasmid DNA was required, minipreps were scaled-up 
appropriately.  
 
2.19 Restriction digestion, gel extraction and ligation of DNA 
 
DNA restriction digests were performed using enzymes from New England Biolabs 
(NEB). Digests were performed in compatible reaction buffers and at the appropriate 
temperatures and enzyme concentrations recommended by NEB. For cloning purposes, 1-5 
g of plasmid DNA was generally used in each digest. For analytical purposes (ie. to verify 
the presence of an insert), about 100 ng of plasmid DNA was used in each digest.  
Products from restriction digests (and some PCR products) were purified by gel 
extraction using the QIAquick Gel Extraction Kit (Qiagen): Digests were subject to 
electrophoresis on 1% agarose gels containing ethidium bromide. Bands were visualized 
using a UV transilluminator and the desired band was excised from the gel using a clean 
razor blade. The agarose slice was weighed, and 300 l of buffer QG was added for each 
100 mg of gel. The gel slice was then dissolved by incubating at 50oC for 10-15 minutes, 
after which 1 gel volume of isopropanol was added. The sample was then added to a 
QIAquick silica column, and spun in a microfuge to bind DNA. Columns were then washed 
with buffer QG and buffer PE, before DNA was eluted into buffer EB (10 mM Tris, pH 8.5).  
 Ligation of both PCR products (blunt-end ligation) and restriction digest products 
(sticky-end ligation) into plasmids was performed using the Quick T4 Ligation Kit (NEB). 30 
l ligation reactions were generally performed, containing: 2 l Quick T4 DNA ligase, 15 l 
2X Quick Ligase Buffer (132 mM Tris-HCl, 20 mM MgCl2, 2 mM dithiothreitol, 2 mM ATP, 
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15% Polyethylene glycol, pH 7.6), 50-100 ng plasmid DNA, and 3-fold molar excess of insert 
DNA. Often, optimal vector:insert ratio was determined empirically. Ligation reactions were 
incubated at 25oC for 1 hour, chilled briefly on ice, and then transformed into E. coli.  
 
2.20 Insect cell culture 
 
 All baculovirus production and recombinant protein expression was carried out 
using Sf9 insect cells (a clonal isolate of the fall armyworm Spodoptera frugiperda). All Sf9 
cell culture was performed at 27oC and in Sf-900 II serum-free medium (Sf-900 II SFM; 
Gibco) supplemented with 50 units/mL penicillin and 50 g/mL streptomycin (Gibco). Cells 
were maintained as adherent cultures in T-75 flasks and split 1:5 when ~90% confluent 
(every 5-6 days). Suspension cultures were initiated from T-75 flasks and grown in glass 
spinner flasks (Corning) on magnetic stir plates or in 2L plastic roller bottles (Corning) 
placed upright in a shaking incubator. A maximum of 500 mL of cell culture was grown in 
roller bottles, and spinner flasks were filled to no more than 50% of the indicated capacity. 
The side arm caps of spinner flasks and lids of roller bottles were closed loosely, to allow for 
aeration. Suspension cultures were maintained at cell densities between 0.6 x 106/mL and 
3.0 x 106/mL. After being unthawed from frozen stocks, Sf9 cells were passaged for no 
longer than 6 months. For production of frozen cell stocks, a suspension culture was grown 
to a cell density of 1.5 x 106/mL. Cells were pelleted by spinning at 400 x g for 5 minutes, 
and resuspended in freezing medium (50% conditioned media, 50% fresh Sf-900 II SFM 
containing 7.5% DMSO) to a final density of 2.0 x 106 cells/mL. 1.5 mL aliquots of cells were 
frozen slowly by placing them at -80oC sealed in Styrofoam, and then left at -80oC for 
storage.  
 
2.21 Construction of bacmids for Mto1/2 expression in insect 
cells 
 
 Mto1 and Mto2 coding sequences were first cloned into the MultiBac acceptor 
plasmid pFL, and subsequently incorporated into the EMBacY bacmid via Tn7 transposition 
(Trowitzsch et al., 2010)(Figure 2.2). The plasmid pFL contains multiple cloning sites (MCS) 
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downstream of the p10 and polh (polyhedrin) promoters used for expression of 
recombinant proteins. Mto1 constructs were cloned into the p10 MCS using the NcoI and 
NsiI restriction sites, while Mto2 constructs were cloned into the polh MCS using the BamHI 
and SalI restriction sites. Mto2 inserts were designed with restriction sites for the BamHI-
compatible enzyme BclI, as the Mto2 coding sequence contains BamHI sites. All Mto1 
constructs included an N-terminal 6-histidine tag (6His) and TEV protease site (6His-TEV-
Mto1, 6His-TEV-Mto1-NE, and 6His-TEV-Mto1-bonsai were constructed). Note that Mto1-
NE and Mto1-bonsai are truncation mutants of Mto1 (described in chapters 3 and 4). For 
co-expression with Mto1, Mto2 was included with no tags. For individual purification of 




PCR was used to amplify Mto1 and Mto2 sequences flanked with the appropriate 
restriction endonuclease sites, 6His tags, and TEV sites. The templates for PCR were pKS272 
and pKS415, which contain the Mto1 and Mto2 coding sequences.  
 
Table 2.4: Mto1 and Mto2 PCR products generated for cloning into pFL acceptor 





NcoI-6His-TEV-Mto1-NsiI OKS2181 / OKS2183 pKS272 
NcoI-6His-TEV-Mto1-NE-NsiI OKS2181 / OKS2184 pKS272 
NcoI-6His-TEV-Mto1-bonsai-NsiI OKS2182 / OKS2184 pKS272 
BclI-Mto2-SalI OKS2185 / OKS2186 pKS415 
BclI-6His-TEV-Mto2-SalI OKS2320 / OKS2186 pKS415 
 
 
PCR products were gel-purified, ligated into pJET1.2/blunt (Fermentas) by blunt-
end cloning, and transformed into TOP10 cells for amplification. Plasmids were then 
isolated by miniprep and sequences of Mto1 and Mto2 constructs were verified by DNA 
sequencing. Standard restriction digest and ligation methods (section 2.19) were then used 
to isolate the Mto1 and Mto2 constructs from pJET1.2/blunt and clone them into pFL. 
 Recombinant bacmids were then generated via Tn7 transposition. The various pFL 
constructs containing Mto1 and Mto2 were transformed into DH10 EMBacY E. coli cells. 
DH10 EMBacY cells harbour the EMBacY bacmid (baculovirus genome) as well as a “helper” 
plasmid. This helper plasmid provides the Tn7 transposon complex required for 
transposition of the pFL expression cassette into EMBacY (Trowitzsch et al., 2010). 
Successful transposition disrupts the LacZ gene on EMBacY (Figure 2.2), such that positive 
clones can be selected for by blue/white screening. Following transformation with pFL 
constructs, DH10 EMBacY cells were therefore plated to LB containing kanamycin (50 
g/mL), tetracylcine (10 g/mL), gentamicin (7 g/mL), isopropyl β-D-1-
thiogalactopyranoside (IPTG; 0.2 mM), and 5-bromo-3-indolyl-beta-galactoside (Bluo-Gal; 
200 g/mL). Kanamycin, gentamicin, and tetracycline resistance are conferred by EMBacY, 
pFL expression cassette, and Tn7 helper plasmid, respectively. White colonies were picked 
and streaked to plates (same composition as above) to verify a true white phenotype, 
indicating successful transposition.  
Bacmid DNA was isolated from E. coli as follows: cells from white colonies were 
grown overnight at 37oC in LB containing kanamycin (50 g/mL), tetracylcine (10 g/mL), 
and gentamicin (7 g/mL). 1.5 mL of cell culture was used for each bacmid preparation. 
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Cells were spun for 1 minute in a microfuge (13000 RPM) and resuspended in 300 L of 
buffer P1 (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 100 g/mL RNase A). 300 L of lysis buffer 
P2 (200 mM NaOH, 1% SDS) was then added, and lysis was allowed to proceed for 5 
minutes. 300 L of neutralization buffer P3 (3.0M potassium acetate, pH 5.5) was added, 
and samples were placed on ice for 10 minutes. Samples were then spun for 15 minutes at 
13000 RPM, after which supernatants were transferred to fresh tubes containing 800 L of 
isopropanol and chilled on ice for 10 minutes. DNA was pelleted by spinning at 13000 RPM 
for 15 minutes, and then washed with 2X 0.5 mL 70% ethanol. DNA was again pelleted 
(13000 RPM, 5 minutes), air dried in a sterile hood, and gently resuspended in 40 L TE.  
 
 
2.22 Generation of virus stocks 
 
 Isolated bacmid DNA was transfected into Sf9 cells in order to produce an initial 
virus stock (V0). Transfections were performed using Fugene HD transfection reagent 
(Roche). For each transfection, 20 L of Fugene HD was added to 400 L of Sf-900 II SFM 
and incubated for 5 minutes at room temperature. 40 L of bacmid DNA was then added to 
the Fugene HD/SFM mix and incubated for 30 minutes at 27oC. 100 L of this mixture was 
then added to 1-2 x 106 cells in each of 4 wells in a 6 well plate.  Approximately 48 hours 
later, media from each well was harvested and pooled as V0. Fresh Sf-900 II SFM was then 
added to transfected cells, and protein expression was confirmed by Western blot following 
an additional 24-48 hours. V0 was then used to scale up to higher volume, more infective V1 
virus stock. 3-5 mL of V0 was added to a 50 mL suspension culture at 0.6 x 10
6 cells/mL. Cell 
counts were monitored and maintained below 1.0 106 /mL until proliferation arrest 
(typically 1-2 days). Cells were pelleted at 400 x g for 5 minutes and media harvested as V1 
48 hours after proliferation arrest. The same general process was then repeated to 
generate V2 virus stocks from V1 (500 mL suspension cultures were infected with 5 mL of V1 
stock). V2 stocks were stored at 4
oC protected from light and used to infect Sf9 cells for 







2.23 Characterization of V2 virus stocks and expression of 
recombinant Mto1/2 
 
 V2 virus stocks were characterized before protein expression was scaled up. The 
aim was to determine the volume of V2 stock that resulted in essentially simultaneous 
infection of all cells in a culture and nearly immediate proliferation arrest, while generating 
optimal protein expression. Therefore, suspension cultures of Sf9 cells (at 0.8-1.0 x 106 
cells/mL) were infected with various volumes of V2. Cell counts were determined using a 
Countess Automated Cell Counter (Invitrogen), to check for proliferation arrest. For 4 days 
following infection, total and soluble protein expression was monitored by Western blot. 
On each day following infection, a 1.5 mL sample of cells was pelleted and resuspended in 
300 L of lysis buffer (1.5 mM KH2PO4, 5.1 mM Na2HPO4, 300 mM NaCl, 5% glycerol, 0.1% 
triton X-100, pH 8.0). Samples were then sonicated in a Bioruptor bath sonicator 
(Diagenode)(6 x 20 seconds on high setting). A sample of whole cell extract (WCE) was 
taken. Samples were then spun for 30 minutes at 13000 RPM and 4oC, and a sample of the 
soluble lysate (SL) was taken. WCE and SL samples were added to 2X Laemmli sample 
buffer, and subjected to 10% SDS-PAGE followed by anti-Mto1 and anti-Mto2 Western 
blotting. For essentially all viruses tested, optimal soluble expression was observed after 3 
days, using virus at 1:50-1:100 dilution in Sf9 suspension cultures at 0.8-1.0 x 106 cells/mL.  
EMBacY also encodes yellow fluorescent protein (YFP) expressed form the polh 
promoter. YFP expression in cells was observed by fluorescence microscopy, as an indirect 
indicator of Mto1/2 expression. This allowed us to verify that all cells were infected and 
expressing protein, and also provided a qualitative measure of protein expression levels (ie. 
brighter cells corresponded to increased expression). Once V2 stocks had been 
characterized by Western blot, YFP expression was monitored to confirm expression when 








2.24 Nickel purification of 6His-Mto1-bonsai, 6His-Mto2, and 
6His-Mto1/2-bonsai complex 
 
 Sf9 suspension cultures were infected with an appropriate amount of V2 (as 
described above) and harvested 3 days post-infection. For harvesting, cells were spun at 
400 x g for 5 minutes, washed with PBS, and then spun again. Pellets (in 50 mL or 200 mL 
falcon tubes) were then flash-frozen in liquid nitrogen and stored at -80oC. 6His-Mto1-
bonsai, 6His-Mto2, and 6His-Mto1/2-bonsai complex were purified by essentially the same 
procedure. Pellets corresponding to 400 mL of Sf9 suspension culture were generally used 
for purification, to generate 1-3 mg of purified protein. Buffer A (1.5 mM KH2PO4, 5.1 mM 
Na2HPO4, 300 mM NaCl, 5% glycerol, pH 8.0) was used throughout all purification steps, 
with pH adjusted to 8.0 again after addition of imidazole. Cell pellets were thawed on ice 
and resuspended in lysis buffer (Buffer A + 0.1% triton X-100, 45 mM imidazole). Pellets 
were then incubated in lysis buffer on ice for 15 minutes, and dounced 20X in a glass 
Wheaton tissue grinder with a loose pestle. Nuclei and large cell debris were pelleted by 
centrifuging for 10 minutes at 400 x g and 4oC in a tabletop Heraeus Megafuge 40R.  
Supernatants from this low-speed spin were then centrifuged for 5 minutes at 100000 RPM 
and 4oC, using a TLA120.2 rotor in a Beckman Coulter tabletop ultracentrifuge. The 
resulting soluble lysate was added to nickel-charged His-bind Fractogel (Merck), which had 
been previously washed in buffer A containing 45 mM imidazole. Lysates were left to 
incubate with Fractogel beads for 20-30 minutes at 4oC on a roller. Beads with bound 
protein were then added to a polypropylene column and washed extensively (~200 mL) 
with wash buffer (Buffer A + 90 mM imidazole). 6His-Mto1-bonsai and 6His-Mto1/2-bonsai 
complex were eluted with buffer A containing 300 or 600 mM imidazole. 6His-Mto2 
required 600 mM imidazole to be eluted. Eluates were then concentrated to 0.5-1.0 mL by 
spinning for ~15 minutes (4000 x g and 4oC) in a centrifugal filter unit with a 30 kDa 







2.25 Gel filtration chromatography and SEC-MALS 
 
 As a second purification step, Ni-purified 6His-Mto1-bonsai, 6His-Mto2, and 6His-
Mto1/2-bonsai complex were fractionated by gel filtration on a Superose 6 10/300 GL 
column (GE Healthcare). Chromatography was performed using an ÅKTA fast protein liquid 
chromatography (FPLC) unit. Prior to running samples, the FPLC and Superose 6 column 
were washed with dH2O and equilibrated with two column volumes (48 mL) of buffer A. 500 
L samples, typically containing 1-2 mg of protein, were injected onto the column. Samples 
were run at 0.5 mL/min and 1.2 MPa, with 36.0 mL of buffer A being passed over the 
column. 250 L or 500 L fractions were collected using an automated fraction collector. 
Samples of fractions were prepared in Laemmli sample buffer and analyzed by 10% SDS-
PAGE followed by Coomassie staining or Western blotting. Size-exclusion chromatography 
with multi-angle light scattering (SEC-MALS) was performed using an ÅKTA FPLC and 
superose 6 10/300 GL column coupled with an on-line UV detector, 18-angle light scattering 
detector (Wyatt Dawn Heleos II), and refractive index detector (Wyatt Optilab rEX). 
Samples were run under the same conditions as described above for standard gel filtration 
chromatography. The 3 peak Mto1/2-bonsai fractions (750 L total) from a Superose 6 run 























KS515 h+ ade6-M210 ura4-D18 leu1-32  Sawin Lab 
KS516 h- ade6-M216 ura4-D18 leu1-32  Sawin Lab 
KS819 h+ mto1-GFP::kanMX ura4-D18 leu1-32 ade6-M216 
 
Sawin Lab 
KS1017 h+ mto1∆::kanMX6 ade6-M216 leu1-32 ura4-D18 Sawin Lab 
KS1407 h– mto1-GFP:kanMX mto2∆::kanMX6 ura4-D18 leu1-32 ade6-
M216 mto2 
Sawin Lab 
KS1999 h- mto1(1-800)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 Sawin Lab 
KS2738 h– mto1-GFP:kanMX6 kanMX6:nmt81:GFP-atb2 ade6-216 leu1-
32 ura4-D18 
Sawin Lab 
KS2802 h+ hphMX6:nmt81:GFP-atb2 ade6-210 leu1-32 ura4-D18 Sawin Lab 
KS3887 h+ kanMX6:nmt81:mto1-GFP:hphMX ura4-D18 leu1-32 ade6-
M216 
Sawin Lab 
KS5186 h– mto1∆::natMX6 hphMX6:nmt81:GFP-atb2 ade6-216 leu1-32 
ura4-D18 
Sawin Lab 
KS5207 h- mto1(1-500)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 This study 
KS5209 h- mto1(1-549)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 This study 
KS5211 h- mto1(1-575)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 This study 
KS5213 h- mto1(1-637)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 This study 
KS5215 h- mto1(1-683)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 This study 
KS5217 h- mto1(1-732)-GFP:kanMX6 ade6-210 leu1-32 ura4-D18 This study 
KS5349 h+ mto1(1-549)-GFP:kanMX6 mto2∆::kanMX6 ade6-M216 leu1-
32 ura4-D18 
This study 
KS5356 h+ hphMX6:nmt81:GFP-atb2 alp4-tdT:natMX6 ade6-210 leu1-32 
ura4-D18 
This study 
KS5357 h- mto1(1-549)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 alp4-
tdT:natMX6 ade6-210 leu1-32 ura4-D18 
This study 
KS5381 h- natMX6:nmt81:mto1(131-1115)-GFP:kanMX ura4-D18 leu1-
32 
This study 
KS5385 h- natMX6:nmt81:mto1(131-549)-GFP:kanMX ade6-210 ura4-
D18 leu1-32 
This study 
KS5491 h- mto1(1-549)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 ade6-
210 leu1-32 ura4-D18 
This study 
KS5517 h- natMX6:nmt81:mto1(203-549)-GFP:kanMX6 ade6-210 leu1-
32 ura4-D18 
This study 
KS5520 h- natMX6:nmt81:mto1(242-549)-GFP:kanMX6 ade6-210 leu1-
32 ura4-D18 
This study 
KS5607 h+ mto1(1-549)::kanMX6 ade6-M216 ura4-D18 leu1-32 This study 
KS5641 h+ mto1(1-549):kanMX6 hphMX6:nmt81:GFP-atb2 alp4-
tdT:natMX6 ade6-M216 ura4-D18 leu1-32 
This study 
KS5645 h- mto1(1-549)-GFP::kanMX6 alp16∆::natMX6 
hphMX6:nmt81:GFP-atb2 ade6-210 leu1-32 ura4-D18 
This study 
KS5647 h- natMX6:nmt81:mto1(1-549)-GFP:kanMX6 ade6-210 leu1-32 
ura4-D18 
This study 
KS5674 h- mto1-GFP::kanMX alp4-tdT:natMX6 ura4-D18 leu1-32 ade6-
M216 
This study 
KS5678 h+ mto1(1-549)-GFP:kanMX6 alp4-tdT:natMX6 ade6-210 leu1-
32 ura4-D18 
This study 
KS5749 h+ mto1(1-9A1-549)-GFP ade6-216 leu1-32 ura4-D18 This study 
KS5817 h- mto1aa1-130)::ura4+ ade6-M216 ura4-D18 leu1-32 This study 
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KS5826 h- mto1(1-800)-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS5851 h- mto1(131-1115) ade6-M210 ura4-D18 leu1-32 This study 
KS5853 h- mto1(203-1115) ade6-M210 ura4-D18 leu1-32 This study 
KS5855 h- mto1(242-1115) ade6-M210 ura4-D18 leu1-32 This study 
KS5922 h- mto1(131-549)-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS5924 h- mto1(203-549)-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS5926 h- mto1(242-549)-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS5929 h+ mto1(131-549)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 ade6-
M210 ura4-D18 leu1-32 
This study 
KS5930 h- mto1(203-549)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 ade6-
M210 ura4-D18 leu1-32 
This study 
KS5931 h+ mto1(242-549)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 ade6-
M210 ura4-D18 leu1-32 
This study 
KS5933 h+ mto1(131-549)-GFP:kanMX6 alp4-tdT:natMX6 ade6-M210 
ura4-D18 leu1-32 
This study 
KS5936 h+ mto1(1-500)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 alp4-
tdT:natMX6 ade6-M210 ura4-D18 leu1-32 
This study 
KS5937 h+ mto1(131-549)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 alp4-
tdT:natMX6 ade6-M210 ura4-D18 leu1-32 
This study 
KS5940 h- mto1(131-1115)-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS5942 h+ mto1(131-1115) hphMX6:nmt81:GFP-atb2 alp4-tdT:natMX6 
ade6-210 leu1-32 ura4-D18 
This study 
KS5944 h- mto1(131-1115) hphMX6:nmt81:GFP-atb2 ade6-210 leu1-32 
ura4-D18 
This study 
KS6080 h+ mto1(131-9A1-549)-GFP:kanMX6 ade6-216 leu1-32 ura4-
D18 
This study 
KS6086 h- mto1(1-549):kanMX6 hphMX6:nmt81:GFP-atb2 ade6-M216 
ura4-D18 leu1-32 
This study 
KS6098 h- mto1(131-9A1-549)-GFP:kanMX6 mto2∆::kanMX6 ade6-M216 
leu1-32 ura4-D18 
This study 
KS6102 h+ mto1(131-1115)-GFP:kanMX6 hphMX6:nmt81:GFP-atb2 
ade6-M210 ura4-D18 leu1-32 
This study 
KS6103 h- mto1(131-1115)-GFP:kanMX6 alp4-tdT:natMX6 ade6-M210 
ura4-D18 leu1-32 
This study 
KS6315 h+ mto1(131-549)-GFP:kanMX6 alp16∆::natMX6 
hphMX6:nmt81:GFP-atb2 ade6-M210 leu1-32 ura4-D18 
This study 
KS6456 h- mto1(131-549)-GFP:kanMX6 mto2∆::kanMX6 ade6-? leu1-32 
ura4-D18 
This study 
KS6457 h+ mto1(131-549)-GFP:kanMX6 mto2∆::kanMX6 
hphMX6:nmt81:GFP-atb2 ade6-? leu1-32 ura4-D18 
This study 
KS6458 h+ mto2∆::kanMX6 hphMX6:nmt81:GFP-atb2 ade6-? leu1-32 
ura4-D18 
This study 
KS6459 h+ mto1-GFP:kanMX mto2∆::kanMX6 hphMX6:nmt81:GFP-atb2 
ade6-? leu1-32 ura4-D18 
This study 
KS6461 h+ mto1(1-549)-GFP:kanMX6 mto2∆::kanMX6 
hphMX6:nmt81:GFP-atb2  ade6-? leu1-32 ura4-D18 
This study 
KS6626 h- mto1(131-549):kanMX6 ade6-M210 ura4-D18 leu1-32 This study  
KS6635 h? mto1(131-549):kanMX6 hphMX6:nmt81:GFP-atb2 alp4-
tdT:natMX6 ade6-210 leu1-32 ura4-D18 
This study 
KS6637 h? mto1(131-549):kanMX6 hphMX6:nmt81:GFP-atb2 ade6-210 
leu1-32 ura4-D18 
This study 
KS6672 h- kanMX6:nmt81:mto1-GFP:hphMX Z:ADH15:mCherry-
Atb2:natMX6 ade6 leu1-32 ura4-D18 
This study 




KS6675 h+ mto1(1-9A1-549)-GFP:kanMX6 Z:ADH15:mCherry-
Atb2:natMX6 ade6 leu1-32 ura4-D18 
This study 
KS6676 h+ mto1(131-9A1-549)-GFP:kanMX6 Z:ADH15:mCherry-
Atb2:natMX6 ade6 leu1-32 ura4-D18 
This study 
KS6677 h+ mto1(1-549)-GFP:kanMX6 Z:ADH15:mCherry-Atb2:natMX6 
ade6-M210 leu1-32 ura4-D18 
This study 
KS6678 h+ mto1(131-549)-GFP:kanMX6 Z:ADH15:mCherry-
Atb2:natMX6 ade6-M210 leu1-32 ura4-D18 
This study 
KS6679 h+ natMX6:nmt81:mto1(1-549)-GFP:kanMX6 Z:ADH15:mCherry-
Atb2:natMX6 ade6 leu1-32 ura4-D18 
This study 
KS6680 h+ natMX6:nmt81:mto1(131-549)-GFP:kanMX 
Z:ADH15:mCherry-Atb2:natMX6 ade6 leu1-32 ura4-D18 
This study 
KS6682 h- rlc1-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS6684 h- plo1-GFP:kanMX6 ade6-M210 ura4-D18 leu1-32 This study 
KS6715 h- natMX6:Z:ADH15:mCherry-Atb2 ade6 leu1-32 ura4-D18  Sawin Lab 
KS6776 h+ alp4-GFP:hphMX6 natMX6:Z:ADH15:mCherry-Atb2 
mto1(131-549):kanMX6 ade6-210 leu1-32 ura4-D18 
This study 
KS6791 h- mto2-GFP:kanMX6 mto1(131-549):kanMX6 
natMX6:Z:ADH15:mCherry-Atb2 ade6-210 leu1-32 ura4-D18 
This study 
KS6816 h- mto1-GFP:kanMX alp16∆::natMX kanMX6:nmt81:GFP-atb2 
ade6-M216 leu1-32 ura4-D18 
This study 
KS6898 h+ alp6-GFP:kanMX6 natMX6:Z:ADH15:mCherry-Atb2 
mto1(131-549):kanMX6 ade6-210 leu1-32 ura4-D18 
This study 
KS7055 h+ mto2-GFP:kanMX6 natMX6:Z:ADH15:mCherry-Atb2 ade6-
216 leu1-32 ura4-D18 
This study 
KS7056 h- mto2-GFP:kanMX mto1∆::kanMX6 
natMX6:Z:ADH15:mCherry-Atb2 ade6-216 leu1-32 ura4-D18 
This study 




















Table 2.6: List of plasmids used in this study.  
Plasmid 
number 
Vector Insert Source 
pKS108 pFA6a-kanMX6 none Sawin Lab 
(Bahler et 
al., 1998) 
pKS112 pFA6a-GFP(S65T)-kanMX6 none Sawin Lab 
(Bahler et 
al., 1998) 
pKS131 pHN159 ura4+ H. Ohkura 
pKS272 pBS mto1+ Sawin Lab 
pKS415 pGEX-4T-2 mto2+ Sawin Lab 
pKS706 pFA6a-natMX6-P81nmt1 none Sawin Lab 
(Bahler et 
al., 1998)  
pKS1215 pJET1.2/blunt 6His-TEV-mto1 This study 
pKS1216 pJET1.2/blunt 6His-TEV-mto1(1-549) This study 
pKS1217 pJET1.2/blunt 6His-TEV-mto1(131-549) This study 
pKS1218 pJET1.2/blunt mto2+ This study 
pKS1219 pFL none Trowitzsch 
et al., 2010 
pKS1220 pFL 6His-TEV-mto1 This study 
pKS1221 pFL 6His-TEV-mto1(1-549) This study 
pKS1222 pFL 6His-TEV-mto1(131-549) This study 
pKS1223 pFL 6His-TEV-mto1, mto2+ This study 
pKS1224 pFL 6His-TEV-mto1(1-549), mto2+ This study 
pKS1225 pFL 6His-TEV-mto1(131-549), 
mto2+ 
This study 
pKS1226 pFL mto2+ This study 
n/a pFL 6His-TEV-mto2 This study 
n/a pJET1.2/blunt 6His-TEV-mto2 This study 

























































































































3. Truncation of the Mto1 C-terminus reveals Mto1 
localization to the nuclear envelope 
 
3.1 Introduction  
 
 Free -TuC is thought not to be active, suggesting that localization of the -TuC to 
MTOCs is necessary for MT nucleation. However, the mechanism of -TuC activation at 
MTOCs is unknown, making the identification of -TuC-activating proteins a topic of 
particular interest. Whether or not the proteins involved in localizing the -TuC are also 
involved in activating the -TuC remains unclear. CDK5RAP2 is a notable exception, as 
recent evidence suggests it is a -TuC activator (Choi et al., 2010). CDK5RAP2 contributes to 
-TuC localization to the centrosome, and both full-length CDK5RAP2 as well as a fragment 
containing its -TuC-binding CM1 domain promote MT nucleation from purified -TuRCs 
(Choi et al., 2010; Fong et al., 2008). The budding yeast -TuC targeting protein Spc110 fails 
to activate nucleation from purified-TuCs, but is capable of promoting the multimerization 
of -TuSCs into -TuRC-like structures (Kollman et al., 2010). According to the template 
model for MT nucleation, such multimerization is a requirement for generating an active -
TuC.  
 Cytoplasmic MT nucleation in fission yeast invariably requires the -TuC localizing 
protein Mto1, thus making Mto1 a suspected -TuC activator. Like a variety of proteins 
involved in -TuC localization and/or activation, Mto1 is a relatively large (1115 amino acid) 
protein that contains extensive predicted coiled-coils as well as a CM1 domain (Samejima et 
al., 2008). Detailed characterization has revealed how various regions of Mto1 primary 
sequence are involved in specific Mto1 functions. Mutations within the Mto1 CM1 region 
eliminate interaction between the Mto1/2 complex and -TuC, resulting in a complete lack 
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of cytoplasmic MT nucleation (Samejima et al., 2008). Deletion of the Mto1 sequence 
required for Mto2-binding, on the other hand, limits Mto1 localization and MT nucleation 
almost exclusively to the SPB (Samejima et al., 2008).  
 An additional Mto1 sequence, referred to as MASC, mediates Mto1/2 localization 
to interphase and mitotic SPBs, as well as the eMTOC (Samejima et al., 2010). The MASC 
region is located near the Mto1 C-terminus, while the Mto2-binding and CM1 domains are 
located more centrally. Mto1 C-terminal truncation mutants lacking the MASC sequence, 
such as Mto1(1-1051)-GFP, retain localization to MTs and the NE, and are capable of 
promoting MT nucleation from non-SPB sites  (Samejima et al., 2010).  
 In this chapter, my aim was to determine how much of the Mto1 C-terminus could 
be removed, while still preserving MT nucleation within the cytoplasm. By extension, I 
wished to determine whether or not a specific region of Mto1 contributed directly to 
activation of the -TuC. Therefore, a series of mto1 mutants with increasingly large C-
terminal deletions was constructed and analyzed with respect to morphology, Mto1/-TuC 
localization, and MT nucleation.  I found that mto1 mutants as small as mto1(1-549) retain 
the ability to nucleate cytoplasmic MTs. Mto1(1-549) fails to localize to MT bundles, and 
instead shows enhance localization to the NE. This leads to increased recruitment of the -












3.2.1 Normal morphology is observed in mto1 truncation mutants as 
small as mto1(1-549) 
 
 PAIRCOIL2 software predicts that Mto1 contains regions of coiled-coils throughout 
much of its sequence, with the exception of the first 275 or so N-terminal residues (Figure 
3.1A). Prediction of coiled-coils by the PAIRCOIL2 program is based on comparison of a 
target protein sequence to a database of two-stranded coiled-coil sequences (Berger et al., 
1995; McDonnell et al., 2006). I used the PAIRCOIL2 analysis of Mto1 sequence as  a rough 
guideline in generating mto1 C-terminal truncation mutants. Truncations were targeted to 
sites between regions of predicted coiled-coil, in order to reduce the possibility of 
disrupting important structural features. The endogenous mto1+ gene was simultaneously 
truncated and tagged with GFP to produce mto1(1-800)-GFP, mto1(1-732)-GFP, mto1(1-
683)-GFP, mto1(1-637)-GFP, mto1(1-575)-GFP, mto1(1-549)-GFP, and mto1(1-500)-GFP 
mutants (Figure 3.1B).  
 As an initial test for mto1 function, I analyzed the various truncations with respect 
to morphology. Previous work has revealed that both mto1 and mto2 cells exhibit a 
curved morphology, due to a lack of proper cytoplasmic MT nucleation and organization 
(Samejima et al., 2005; Sawin et al., 2004; Venkatram et al., 2005; Venkatram et al., 2004). 
This phenotype is most evident when cells are re-introduced to fresh media following 
growth to stationary phase. Wild-type and mutant mto1 strains were therefore allowed to 
re-grow from stationary phase, fixed in formalin, and imaged by differential interference 
















 As expected, wild-type (mto1+) and full-length mto1-GFP cells exhibited normal, 
straight morphology, while mto1 cells were clearly curved. Truncations as small as 
mto1(1-549)-GFP showed wild-type morphology, providing an initial indication that mto1 
function was not abolished following extensive C-terminal truncation.  Un-tagged mto1(1-
549) was therefore also analyzed, to verify that capping of the truncated Mto1 C-terminus 
by GFP was not necessary to maintain Mto1 function and/or  stability.  Like mto1(1-549)-
GFP, mto1(1-549) was found to have a wild-type cell shape. In contrast, mto1(1-500)-GFP 
was found to be curved, suggesting a decrease or lack of Mto1 function . This is consistent 
64 
 
with the finding that a central portion of Mto1, roughly encompassing amino acids 461-549, 
is required for interaction with Mto2 (Samejima et al., 2005; Samejima et al., 2008). 
Internal deletions within this region eliminate the Mto1-Mto2 interaction, resulting in a 
phenotype that mimics mto2, including defects in cytoplasmic MT nucleation and curved 
morphology (Samejima et al., 2008). 
 
 
3.2.2 Mto1 C-terminal truncations localize to the nuclear envelope 
 
 Localization of the GFP-tagged truncation mutants was analyzed, and compared to 
that of full-length Mto1-GFP. During interphase, full-length Mto1 localizes primarily to the 
SPB and sites along MTs, although occasional satellite particles of Mto1 can be detected on 
the NE (Figure 3.3A) (Sawin et al., 2004; Venkatram et al., 2004). In previous work, it was 
shown that Mto1 over-expression results in decoration of MTs and increased NE 
localization, with Mto1 appearing as a faint ring around the NE (Samejima et al., 2005).  
Here, all of the C-terminal truncations ranging in size from Mto1(1-800)-GFP to Mto1(1-
549)-GFP were found to localize almost exclusively to the NE (Figure 3.3A). Unlike the "ring" 
of Mto1 seen on the NE upon over-expression, the C-terminal truncation mutants were 
visible as discrete puncta. Movies of Mto1(1-549)-GFP revealed that these puncta were 
dynamic, appearing to diffuse around the nuclear surface. Limited numbers of puncta were 
also observed in the cytoplasm away from the NE, where they exhibited rectilinear 
movements indicative of an association with MTs.  
 Mto1(1-500)-GFP showed no specific localization, instead producing only a diffuse 





Mto1 re-distributes to the NE upon cold-shock. Although the mechanism is unknown, this 
re-distribution of Mto1 to the NE does not occur in mto2 cells  (Samejima et al., 2005). 
Therefore, Mto1(1-500)-GFP likely fails to localize to the NE owing to a lack of an intact 
Mto2-binding region. The findings presented here thus confirm that under physiological 
conditions and endogenous expression, Mto1 localizes to the NE in an Mto2-dependent 
manner.  
 We hypothesized that the -TuC itself could be re-distributed to the NE when not 
localized to conventional MTOCs by the Mto1 C-terminal truncations. If this were the case, 
the Mto1 C-terminal truncations could be recruited to the NE by the -TuC, rather than the 
-TuC being recruited to the NE by Mto1.  To address this possibility, I generated a C-
terminal truncation of the mto1-9A1 mutant. In mto1-9A1, 9 residues within the CM1 
region are mutated to alanine, leading to a lack of interaction between Mto1 and the -TuC 
(Samejima et al., 2008). Mto1(1-549)-GFP and Mto1(1-9A1-549)-GFP were imaged along 
with mCherry--tubulin (Figure 3.3B). The lack of normal cytoplasmic MT arrays in mto1(1-
9A1-549)-GFP was taken as an indirect confirmation that Mto1(1-9A1-549)-GFP failed to 
interact with the -TuC, as with full length Mto1-9A1. Like Mto1(1-549)-GFP, Mto1(1-9A1-
549)-GFP localized to the NE, indicating that interaction with the -TuC is not necessary for 
Mto1 NE localization (Figure 3.3B).  
 I also wanted to confirm that Mto1(1-549) was capable of recruiting the -TuC to 
the NE. Therefore, the -TuC protein Alp4-tdTomato (Alp4-tdT) was imaged along with GFP-
-tubulin (nmt81:GFP-Atb2) in wild-type, mto1(1-549), and mto1(1-549)-GFP backgrounds. 
As expected, in a wild-type background Alp4-tdT was observed at the iSPB, mSPBs, NE and 
eMTOC, as well as along MTs (Figure 3.4, Figure 3.5). In mto1(1-549) and mto1(1-549)-GFP 
cells, on the other hand, Alp4-tDT localized mostly to the NE, but could also be observed at 












observed in mto1 and cells lacking the MASC region, and is thought to correspond to -
TuC localized to the nucleoplasmic face of the SPB in an Mto1-independent manner 
(Samejima et al., 2010). This is supported by the absence of cytoplasmic astral MTs in both 
mto1(1-549) and mto1(1-549)-GFP (Figure 3.5). Astral MTs are also absent in mutants that 
lack the MASC region but retain most of mto1 C-terminus, such as mto1(1-1051)-GFP 
(Samejima et al., 2010).  
 In mto1(1-500)-GFP, Alp4-tdT showed no specific cytoplasmic localization, and cells 
failed to nucleate cytoplasmic MT arrays (Figure 3.4). This confirms that Mto1(1-500)-GFP, 
in which the Mto1-Mto2 binding region is disrupted, fails to promote MT nucleation from 
the -TuC.  
 Next, I wished to determine whether or not Mto1(1-549) retained localization to 
MT bundles. However, this was complicated by the fact that we suspect Mto1 localizes to 
MTs via two mechanisms. In the first mechanism, Mto1 associates directly with the MT 
lattice, and therefore localizes along the length of existing MT bundles. In the second 
mechanism, Mto1 remains associated with the minus-end of a MT following nucleation. 
Importantly, if this MT is incorporated into an existing MT bundle, Mto1 can appear as 
though it is associated with the MT lattice. Therefore, any mto1 mutant capable of 
nucleating MTs is expected to show some Mto1 localization to MT bundles.  
 Localization of full-length Mto1 to the MT lattice is demonstrated by over-
expression of nmt81:Mto1-GFP, which results in a complete decoration of MT bundles 
(Figure 3.6) (Samejima et al., 2005). Over-expressed nmt81:Mto1(1-549)-GFP, on the other 
hand, failed to decorate MTs. In fact, nmt81:Mto1(1-549)-GFP showed  no increase in MT 
localization when compared to endogenously-expressed Mto1(1-549)-GFP (Figure 3.6). This 
suggests that Mto1(1-549) localization to MTs may be limited to MT minus ends. Consistent 
with this notion, endogenously-expressed Mto1(1-549)-GFP showed reduced localization to 
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MTs, when compared with Mto1-GFP (Figure 3.6). Similarly, Alp4-tdT had reduced 
localization to MTs in mto1(1-549)-GFP and mto1(1-549) cells, in comparison to cells 
expressing full-length Mto1 (Figure 3.4). Overall, these findings suggest that Mto1(1-549) is 
not targeted to the MT lattice. Given that Mto1(1-549)-GFP and Mto1(1-800)-GFP 
localization is essentially indistinguishable (Figure 3.3A) and that the MASC sequence is not 
necessary for MT localization (Samejima et al., 2010), residues between amino acid 800 and 
the MASC sequence probably mediate Mto1 targeting to MTs. 
 Mto1(1-549)-GFP was imaged together with Alp4-tdT, in order to confirm that they 
co-localized on the NE. As a control, Mto1-GFP was found to co-localize with Alp4-tdT on 
MTs, SPBs, and the eMTOC, as described previously (Figure 3.7) (Samejima et al., 2008). By 
contrast, Mto1(1-549)-GFP and Alp4-tdT co-localized predominantly on the NE, but also 
occasionally in the cytoplasm (Figure 3.7).  In maximum projections through the full cell 
volume, Mto1(1-549)-GFP signal often overlapped partially with Alp4-tdT signal at the SPB. 
However, inspection of the specific Z-sections containing the SPB signal confirmed that 
Mto1(1-549)-GFP fails to localize to the SPB, as expected owing to deletion of the MASC 
sequence (Figure 3.7). Both Mto1-GFP and Mto1(1-549)-GFP were occasionally observed on 
their own, with no associated Alp4-tdT signal. This is consistent with the notion that Mto1 is 
























3.2.3 Mto1(1-549) promotes increased MT nucleation from the NE 
 
 Although MTs in mto1(1-549) were qualitatively normal (Figure 3.4), we wished to 
verify that the C-terminal truncation mutants were capable of nucleating MTs. We 
confirmed de novo MT nucleation using both fixed- and live-cell assays. mto1-GFP and 
mto1(1-549)-GFP cells were subjected to MT re-growth experiments, in which cells were 
chilled on ice to induce MT depolymerization and then returned to  25oC to allow for MT re-
assembly. Figure 3.8 shows cells fixed and stained by anti-tubulin immunofluorescence. 
Cells were fixed prior to chilling, and also 0, 1, 3, and 10 minutes after being returned to 
25oC. In both mto1-GFP and mto1(1-549)-GFP, equally robust MT re-growth could be 
observed by 1 minute, and MT arrays appeared to be at steady state by 3 minutes. This 
suggests that extensive truncation of the Mto1 C-terminus has little or no effect on the 
ability of cells to nucleate new MTs. Nucleation in both strains occurred predominantly 
from the area around the nucleus, as described previously for cold-shock experiments with 
mto1+ cells (Anders et al., 2006; Samejima et al., 2005; Samejima et al., 2008; Sawin et al., 
2004; Venkatram et al., 2005). In wild-type cells, the re-growth of MTs from the NE can be 
explained by the re-distribution of Mto1 to the nuclear surface following cold-shock (Sawin 
et al., 2004), while Mto1(1-549)-GFP is already present on the NE even under normal 












 Live-cell imaging of GFP--tubulin was used to compare MT nucleation in mto1+ 
and mto1(1-549) strains. The aim was to address whether re-distribution of Mto1(1-549) to 
the NE—by removal of localization domains rather than cold-shock—would promote 
increased MT nucleation from the NE under normal growth conditions. Cells expressing 
nmt81:GFP-Atb2 in mto1+, mto1-GFP, mto1(1-549), and mto1(1-549)-GFP backgrounds all 
clearly exhibited de novo MT nucleation (Figure 3.9). The frequency and spatial distribution 
of MT nucleation was analyzed by counting nucleation events, and classifying them as 
occurring in the NE region or elsewhere in the cytoplasm. The appearance of a new MT, 
that did not arise from breakage or release from an existing MT bundle, was taken as 
representing a de novo nucleation event. It is important to note that MT nucleation 
occurring along existing MT bundles cannot be identified with confidence,  and thus was 
not counted in this experiment.  
 Both mto1(1-549) and wild-type mto1+ cells exhibited MT nucleation almost 
exclusively from the region around the NE, with only very occasional nucleation events 
occurring freely in the cytoplasm.  Further, the addition of a GFP tag in mto1-GFP and 
mto1(1-549)-GFP had no effect when compared to the respective untagged strain (Figure 
3.9). Notably, the truncated mto1 strains nucleated MTs from the NE at roughly twice the 
frequency of  cells with full-length mto1. This can be explained by the redistribution of 
Mto1(1-549) and the -TuC to the NE, away from additional prospective nucleation sites on 
MTs and the SPB. In cells with full-length Mto1, a much smaller proportion of Mto1 and the 
-TuC are observed on the NE, such that MT nucleation from the NE likely represents only a 
subset of total cytoplasmic nucleation. Importantly, it is unlikely that mto1+ cells nucleate 
fewer MTs overall than mto1(1-549) cells. Instead, much of the nucleation in mto1+ 









 The work presented in this chapter demonstrates that cytoplasmic MT nucleation is 
preserved in mto1 C-terminal  truncation mutants as small as mto1(1-549).  Mto1(1-549) 
retains the Mto1 regions required for -TuC and Mto2 binding but lacks sequences which 
mediate localization to SPBs, MTs, and the eMTOC. Further truncation results in cells which 
fail to nucleate cytoplasmic MT arrays, most likely due  to deletion of Mto1 sequence 
required for interaction with Mto2. This is expected, as mto2 cells are only capable of 
nucleating MTs from the SPB (Samejima et al., 2005). Therefore, simultaneous removal of 
the SPB-localizing and Mto2-binding regions in mto1(1-500)-GFP completely abolishes 
cytoplasmic MT nucleation.  
 Various C-terminal truncations of Mto1, ranging in size from Mto1(1-549)-GFP to 
Mto1(1-800)-GFP, showed clear localization to the NE. Previously, Mto1 had only been 
clearly detectable on the NE when over-expressed or following cold-induced 
depolymerization of MTs (Samejima et al., 2005; Sawin et al., 2004). Mto1(1-549) was also 
found to recruit the -TuC to the NE, resulting in increased MT nucleation from the nuclear 
surface. This finding provides mechanistic insight to the largely unexplained observation 
that the fission yeast NE acts as a MTOC.  Presumably, the same mechanism accounts for 
NE-derived nucleation in wild-type cells, but is simply harder to observe as full-length Mto1 
localizes primarily to MTs and the SPB.   
 Significantly, the findings presented here reveal that re-localizing Mto1 and the -
TuC  in mto1(1-549) does not compromise MT nucleation, but rather alters the spatial 
distribution of MT nucleation within the cell. This provides an initial indication that the role 
of Mto1 in activating the -TuC may be independent of its role in localizing the -TuC. Given 
78 
 
its ability to recruit the -TuC to the NE, and thereby promote increased MT nucleation at 















































4. The Mto1/2-bonsai complex activates MT 
nucleation by the -TuC  
 
4.1 Introduction  
 
 Ultimately, I wished to determine whether or not a particular domain of Mto1 was 
directly involved in activating the -TuC. To address this question, I sought to generate a 
minimal Mto1 mutant which completely lacked localization domains, but retained the 
ability to promote cytoplasmic MT nucleation. In the previous chapter, we saw that the 
Mto1 C-terminus can be truncated to amino acid 549, without compromising MT nucleation 
in the cytoplasm. This Mto1 mutant, referred to as Mto1-NE, does not localize to SPBs, 
MTs, or the eMTOC, but instead shows enhance localization to the NE. In the following 
chapter, I investigate the role of the Mto1 N-terminus in MT nucleation, as well as 
localization of Mto1 and the -TuC.  
 To do this, I generated a series of mto1 N-terminal truncation mutants. This 
revealed that the Mto1 N-terminus is required for localization of the Mto1/2 complex and 
-TuC to the NE. By combining the N- and C-terminal truncations in a single mutant, I 
generated Mto1-bonsai, a minimal fragment of Mto1 that retains the -TuC and Mto2 
binding regions, but lacks both the N- and C-terminal localization domains. Mto1-bonsai 
promotes spatially random MT nucleation from the -TuC, completely independent of 
localization to conventional MTOCs. In addition, live-cell imaging revealed that puncta 
containing both the -TuC and Mto1/2-bonsai complex (Mto1-bonsai-Mto2 complex) are 
present at the ends of newly-nucleated MTs. This provides the most direct evidence to date 
that Mto1 contributes directly to -TuC activation. 
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 Fluorescence quantification was used to determine the copy numbers of GFP-
tagged Mto1-bonsai, Mto2, Alp4, and Alp6 in the puncta associated with MT nucleation. 
This quantification indicates that these nucleating puncta are single -TuRCs, associated 
with 13 copies each of Mto1-bonsai and Mto2. The copy numbers observed for Mto1-
bonsai and Mto2 therefore match the 13 protofilaments of the MT lattice, as well as the 13 
-tubulins thought to produce an effective template for MT nucleation. Most importantly, 






4.2.1 Over-expressed N-terminal truncations of Mto1 promote MT 
nucleation away from the NE 
 
 I produced a series of Mto1 N-terminal truncation mutants,  in the context of both  
the full length Mto1 C-terminus and the truncated Mto1-NE mutant. The N-terminus was 
truncated to amino acid residue 131, 203, or 242, such that the CM1 region, which roughly 
spans amino acids 247-310 (Figure 3.1B) (Samejima et al., 2008), was left intact in all cases.  
Initially, truncations were generated such that Mto1 was over-expressed from the nmt81 
promoter, because construction of these strains was technically simpler than generating N-
terminal truncations expressed from an endogenous promoter.  
 As a first test for MT nucleating function, mto1 N-terminal truncation mutants were 
subjected to cold-shock and MT regrowth assays, exactly as described in section 3.2.3. All of 
the N-terminal truncation mutants were capable of nucleating MTs, but differed in the 
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localization and robustness of MT nucleation. Previous work has shown that wild-type cells 
nucleate MTs from the NE within 1 minute following return to warm media, and exhibit 
steady-state MT arrays within 2-4 minutes (Sawin et al., 2004). In contrast, cells completely 
lacking Mto1 exhibit new MTs only after 10-20 minutes and a return to steady state after 
30-60 minutes (Sawin et al., 2004). Like wild-type and mto1-GFP cells, nmt81:mto1(131-
1115)-GFP, nmt81:mto1(131-549)-GFP, nmt81:mto1(203-549)-GFP, and nmt81:mto1(242-
549)-GFP all nucleated MTs within 1 minute, and appeared to have steady-state MT arrays 
by 3 minutes (Figure 4.1B). MT nucleation did not appear as robust in the N-terminal 
truncation mutants, in particular for nmt81:mto1(203-549)-GFP and nmt81:mto1(242-549)-
GFP. Still, it was clear that all of the mto1 N-terminal truncations retained at least some 
ability to nucleate cytoplasmic MTs. Significantly, unlike cells expressing full-length Mto1, 
the mto1 N-terminal truncations did not exhibit MT re-growth from the NE, but rather 
showed spatially random MT nucleation throughout the cytoplasm (Figure 4.1B).  
 Analysis of Mto1 localization revealed that the N-terminal truncations were absent 
from the NE. This explains the spatially random nucleation observed in cold-shock 
experiments. nmt81:Mto1(131-1115)-GFP did not show the faint NE localization observed 
in nmt81:Mto1-GFP, and instead appeared to show an increased decoration of MTs (Figure 
4.2).  The lack of Mto1 at the NE was much more apparent when the N-terminus of Mto1-
NE was truncated;  while nmt81:Mto1-NE-GFP clearly localized to the NE, nmt81:Mto1(131-
549)-GFP, nmt81:Mto1(203-549)-GFP, and nmt81:Mto1(242-549)-GFP were distributed 
throughout the cytoplasm, often as larger puncta (Figure 4.2). These larger spots may 
represent Mto1 aggregates, which could potentially account for the reduced nucleation 
observed in nmt81:mto1(203-549)-GFP and nmt81:mto1(242-549)-GFP. Indeed, 
nmt81:Mto1(242-549)-GFP showed both the largest spots and the weakest MT nucleation. 
82 
 
Overall, these findings suggested that truncation of the Mto1 N-terminus eliminates NE 







4.2.2 The Mto1 N-terminus mediates localization to the NE  
 
 Strains expressing Mto1 N-terminal truncations from the endogenous mto1 
promoter were also constructed, in order to verify the phenotypes observed with the 
nmt81-expressed mutants. Like their over-expressed counterparts, endogenously-
expressed Mto1(131-549)-GFP, Mto1(203-549)-GFP, and Mto1(242-549)-GFP failed to 
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localize to the NE, confirming that the Mto1 N-terminus was required for NE targeting 




 To prove that this was true in context of the full-length Mto1 C-terminus, 
localization of endogenously-expressed Mto1(131-1115)-GFP was also analyzed. This 
required a modification of our localization assay, because under normal conditions, both 
Mto1-GFP and Mto1(131-1115)-GFP are visible primarily along MT bundles, and neither 
protein is easily detectable on the NE (Figure 4.4). Cells expressing Mto1-GFP or Mto1(131-
1115)-GFP were treated with methyl benzimidazol-2-yl-carbamate (MBC) in order to disrupt 
MTs, and therefore the MT localization of Mto1 . Treatment with 50 g/ml MBC caused 
Mto1-GFP, but not Mto1(131-1115)-GFP, to re-distribute to the NE, indicating that the 
Mto1 N-terminus contains a bona fide NE-localizing domain (Figure 4.4).  That is, results 
obtained with the Mto1 C-terminal truncations were not simply an artefact due to the 
truncation. In the presence of MBC, Mto1(131-1115)-GFP was generally visible as 1-2 large 
spots per cell, which likely corresponded to the SPB and MT stubs left over from incomplete 
depolymerization (Figure 4.4).   
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 These findings suggest a model in which Mto1 is dynamically partitioned between 
various cytoplasmic MTOCs. In wild-type cells, Mto1 is distributed amongst the SPB, MTs, 
and to a lesser extent the NE. Disrupting Mto1 localization to MTs, either by truncating the 
Mto1 C-terminus or depolymerizing MTs by cold-shock or MBC, results in a re-distribution 
of Mto1 to MTOCs on the NE. This suggests that the affinity of Mto1 for MTs and the SPB is 
greater than its affinity for MTOCs on the NE (Figure 4.5). Alternatively, MTs and the SPB 











 Next, I wanted to verify that Mto1(131-549)-GFP failed to decorate the MT lattice, 
as was seen with Mto1-NE-GFP (Figure 3. 6). Although Mto1(131-549)-GFP is observed on 
MT bundles, over-expression of nmt81:Mto1(131-549)-GFP does not result in the MT 
decoration observed with nmt81:Mto1-GFP (Figure 4.6; Figure 3.6).  As described for Mto1-
NE-GFP in Chapter 3, Mto1(131-549)-GFP localization to MTs may therefore be limited 
exclusively to MT minus ends following nucleation. To confirm this, I generated the CM1 
mutant mto1(131-9A1-549)-GFP, which fails to nucleate cytoplasmic MTs. In the absence of 
de novo MT nucleation, Mto1(131-9A1-549)-GFP failed to associate with cytoplasmic MTs 
that had escaped from the nucleus (Figure 4.6), indicating that Mto1(131-549)-GFP is not 
targeted to the MT lattice. Therefore, Mto1(131-549) can be regarded as a "non-localizing" 














 Localization of the -TuC in the mto1 N-terminal truncation mutants was also 
investigated, in order to determine whether or not Mto1 localization to the NE was 
required for -TuC localization to the NE. Simultaneous removal of the N- and C-terminal 
localization domains in mto1(131-549) and mto1(131-549)-GFP essentially abolished the 
Alp4-tdT NE localization observed in mto1-NE (Figure 4.7; Figure 3.4).  However, cells 
expressing Mto1(131-1115), which retains the Mto1 C-terminal localization domains, 
showed normal Alp4-tdT localization to MTs, SPBs, and the eMTOC (Figure 4.7). Very faint 
Alp4-tdT signal could occasionally be detected on the NE in the mto1 N-terminal truncation 
mutants, but overall it is apparent that robust localization of the -TuC to the NE requires 
the Mto1 N-terminus. Further, as seen in mto1(1-549), Alp-tdT in mto1(131-549) and 
mto1(131-549)-GFP showed only very limited association with MT bundles, and was 
presumably limited to MT minus-ends (Figure 4.7). Thus, like Mto1(131-549) itself, the -
TuC in mto1(131-549) appears to be essentially absent from conventional MTOCs.  
 Figure 4.8 shows the co-localization of Alp4-tdT with Mto1(131-1115)-GFP and 
Mto1(131-549)-GFP. As seen with Mto1-GFP and Mto1-NE-GFP, both Mto1(131-1115)-GFP 
and Mto1(131-549)-GFP were occasionally observed on their own, without any associated 
Alp4-tdT signal. Again, this is consistent with the notion that Mto1/2 forms a sub-complex 


















4.2.3 Mto1-bonsai promotes spatially random MT nucleation 
 
 The ability to remove the Mto1 N- and C-terminal localization sequences allowed 
me to directly address an important question: Can cells which express a "non-localizing" 
version of Mto1 still effectively nucleate cytoplasmic MTs, or is -TuC localization to 
conventional MTOCs necessary for MT nucleation?   
 First, I wished to determine how much of the Mto1 N-terminus could be removed 
while preserving cytoplasmic MT nucleation. The more extensive 203- and 242- N-terminal 
truncations of Mto1 appeared to have impaired function. Both mto1(203-1115) and 
mto1(242-1115) cells showed somewhat curved morphology, and this was more 
pronounced when the C-terminus was also truncated, as in mto1(203-549)-GFP and 
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mto1(242-549)-GFP (Figure 4.9A).  By contrast, mto1(131-1115) had wild-type morphology, 
and mto1(131-549)-GFP cells showed only occasional, slight curving. More importantly, 
however, the more extensive mto1 truncation mutants exhibited abnormal cytoplasmic MT 
arrays. Imaging of GFP--tubulin revealed that mto1(203-549)-GFP and mto1(242-549)-GFP 
cells typically contained 1-2 long, curved MT bundles, a characteristic feature of mto1 
(Figure 4.9B). Also, de novo nucleation of MTs was rarely observed in mto1(203-549)-GFP 
and mto1(242-549)-GFP, consistent with the weak MT nucleation observed in regrowth 
experiments with nmt81:mto1(203-549)-GFP and nmt81:mto1(242-549)-GFP (Figure 4.1B).  
 When expressed from the endogenous mto1 promoter, the steady state levels of 
Mto1(203-549)-GFP and Mto1(242-549)-GFP were lower than Mto1(131-549)-GFP (75% 
and 50% of the Mto1(131-549)-GFP expression level, respectively) (Figure 4.9C). This 
reduced expression could account, at least in part, for the compromised MT nucleation 
observed in mto1(203-549)-GFP and mto1(242-549)-GFP cells. 
 Cells expressing Mto1(131-549)-GFP, on the other hand, had qualitatively normal 
MT arrays and frequently nucleated new MTs (Figure 4.9; Figure 4.10). Because it 
represented a minimal, trimmed but functional version of Mto1, Mto1(131-549) was given 
the name "Mto1-bonsai". Quantification of nucleation events revealed that mto1-bonsai 
and mto1-bonsai-GFP nucleated MTs in a spatially random manner (Figure 4.10). This 
clearly differs from mto1+ or mto1-NE cells, where MT nucleation occurrs almost 
exclusively from the NE or the region around the NE (Figure 3.9; Figure 4.10). It is important 
to note that MT nucleation counted in the "nuclear envelope region" includes nucleation 
from the NE itself, as well as nucleation occurring in the cytoplasm adjacent to the NE. 
Therefore, if MT nucleation was spatially random, we would expect to see most nucleation 
events occurring in the larger "cytoplasmic region", but would also expect some nucleation 







 mto1-bonsai-GFP cells (Figure 4.10). Most importantly, these findings demonstrate that 
targeting of Mto1-bonsai/Mto1-bonsai-GFP and the -TuC to conventional MTOCs is not 
necessary for cytoplasmic MT nucleation. This indicates that additional factors present at 
MTOCs are not required for activation of the -TuC.  
 The frequency of MT nucleation in un-tagged mto1-bonsai was considerably lower 
than in mto1-bonsai-GFP. This can be explained by the low expression level of Mto1-bonsai, 
relative to both Mto1-bonsai-GFP and the other Mto1 truncations, as determined by 
western blotting (Figure 4.11). Still, the fairly limited amount of Mto1-bonsai present in 
cells was clearly sufficient to promote MT nucleation. The effect of GFP-tagging on Mto1 
expression levels varied. While tagging increased steady-state levels of Mto1-bonsai, it 
decreased levels of full-length Mto1 and Mto1(131-1115), and had no effect on Mto1-NE 
(Figure 4.11). In  a previous study, C-terminal GFP-tagging was found to decrease the levels 
of full-length Mto1, while increasing the stability of various C-terminal truncation mutants 
ranging in size from Mto1(1-1051) to Mto1(1-1095) (Samejima et al., 2010). Nonetheless, 
with the exception of full-length Mto1, a decrease in protein levels for any given Mto1 
fragment corresponded to a reduction in MT nucleation frequency (Figure 3.9; Figure 4.10; 
Figure 4.11). 
 Truncation of the Mto1 N-terminus did not appear to have a significant effect on 
the frequency of MT nucleation, as Mto1-NE-GFP and Mto1-bonsai-GFP are expressed at 
similar levels and nucleate MTs at comparable rates (0.7 cell-1min-1 compared to 0.5 cell-
1min-1) (Figure 3.9; Figure 4.10; Figure 4.11). Very little  nucleation was observed in 
mto1(131-1115) and mto1(131-1115)-GFP (Figure 4.10). However, this is most likely 
because MT nucleation in these strains occurs primarily along existing MTs or from the SPB, 
and therefore tends to go undetected. Given the normal MT arrays observed in both 
mto1(131-1115) and mto1(131-1115)-GFP, it is clear that these strains are not genuinely 
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deficient in de novo MT assembly (Figure 4.10).  Taken together, these results suggest that 
Mto1 has a distinct role in activating MT nucleation from the -TuC, that is independent of 






4.2.4 Mto1/2-bonsai activates MT nucleation by the -TuC 
  
 I hypothesized that if the Mto1/2 complex was directly involved in activating the -
TuC, it would have to be associated with the -TuC upon MT nucleation, even when MT 
nucleation occurred away from MTOCs in the mto1-bonsai mutant. In other words, I 
predicted that both the -TuC and Mto1/2-bonsai complex would be present at the minus-
ends of MTs during de novo MT nucleation.  Indeed, live-cell imaging with mCherry--
tubulin revealed that Mto1-bonsai-GFP, as well as Mto2-GFP, Alp4-GFP, and Alp6-GFP in an 
mto1-bonsai background, were associated with the ends of newly-nucleated MTs (Figure 
4.12). Imaging was performed at a high time resolution of 1.63 seconds, allowing for the 
unambiguous detection of de novo nucleation events and associated Mto1/2 and -TuC 
puncta. The nucleation of MTs from puncta containing Mto1-bonsai-GFP and Mto2-GFP, in 
addition to the -TuC, strongly suggests that Mto1/2 has a direct role in -TuC activation.  
 Fluorescence quantification was used to determine the stoichiometry  of Mto1/2-
bonsai and -TuC components in the puncta associated with MT nucleation. Such 
quantification would be extremely difficult in mto1+ or mto1-NE, given the "crowded" 
nature of MTOCs in these strains. The spatially random nucleation observed in mto1-
bonsai, on the other hand, allowed for easy identification of individual nucleation events 
and associated nucleating puncta. The intensity of Mto1-bonsai-GFP, Mto2-GFP, Alp4-GFP, 
and Alp6-GFP nucleating puncta at or near the moment of MT nucleation was measured, 
and converted into a number of molecules by comparison to standards imaged under the 
same conditions (Figure 4.13; 4.14). This technique was initially developed in Tom Pollard's 
lab, where the copy numbers of a large variety of cytokinesis proteins were determined by 
a combination of fluorescence microscopy, flow cytometry, and quantitative 
immunoblotting (Wu and Pollard, 2005). Here, I employed GFP-tagged Polo kinase (Plo1-
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GFP) and myosin regulatory light chain (Rlc1-GFP) as standards in determining copy 









 Previous studies have demonstrated that cytokinesis nodes contain on average 41.3 
± 23 molecules of Rlc1 (Laporte et al., 2011), while around 220 molecules of Plo1 are 
present at each SPB during early mitosis (Wu and Pollard, 2005). The intensities of Mto1/2-
bonsai and -TuC puncta were closer to those observed for Rlc1-GFP nodes than for Plo1-
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GFP, with Plo1-GFP signal being approximately an order of magnitude greater (Figure 4.14; 
Figure 4.15). Rlc1-GFP nodes were therefore used as the standard in determining Mto1-
bonsai-GFP, Mto2-GFP, Alp4-GFP, and Alp6-GFP copy numbers.  Plo1-GFP intensity was 
analyzed during each imaging session, in order to confirm the fidelity of intensity 
measurements . As seen in Figure 4.15, the distribution of intensities and  average intensity 
for Plo1-GFP was reproducible across multiple experiments.   
 The Mto1-bonsai-GFP and Mto2-GFP nucleating particles were composed of an 
average of 12.8 and 13.0 molecules, respectively (Figure 4.14). Evidently, this reveals a 1:1 
stoichiometry of Mto1-bonsai:Mto2 in the complexes associated with MT nucleation, and 
suggests that these larger assemblies are composed of some sort of core Mto1/2-bonsai 
subunit, such as a dimer or tetramer. Notably, the value 13 also matches the number of 
protofilaments in a MT, as well as the number of -tubulins thought to be present in single 
-TuRCs.  
 Alp4-GFP and Alp6-GFP also showed very similar intensities, corresponding to an 
average of 8.5 and 8.4 molecules per nucleating puncta, respectively (Figure 4.14). This is 
consistent with existing models of the -TuC, where GCP2 and GCP3 are present in equal 
copy number (Kollman et al., 2010; Kollman et al., 2008). In addition, the values are 
remarkably close to the 6-7 copies of each protein required to produce a -TuC with a 13 -
tubulin template.  
 Overall, these values indicate that the puncta observed correspond to single -
TuRCs, making this the first direct, in vivo observation of individual -TuCs nucleating 
individual MTs. Further, the presence of 13 copies of both Mto1-bonsai and Mto2 implies 
that there are roughly 2 copies of Mto1 and 2 copies of Mto2 associated with each -TuSC 
in a nucleation-competent complex.  This suggests that higher-order assemblies of the 













 Analysis of the mto1-bonsai mutant provides strong evidence that the Mto1/2 
complex is a -TuC activator. MT nucleation occurred directly from particles containing 
Mto1-bonsai-GFP and Mto2-GFP, in addition to the -TuC. Further, MT nucleation was 
found to be spatially random in mto1-bonsai, occurring without -TuC localization to 
conventional MTOCs. Significantly, this reveals that the role of Mto1/2 in activating the -
TuC is independent of its role in localizing the -TuC to specific sub-cellular sites. This also 
shows that additional factors present at MTOCs are not required for -TuC activation and 
MT nucleation. Of course, I cannot rule out the possibility that additional, unidentified 
factors also contribute to -TuC activation, regardless of -TuC localization to MTOCs.  
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 I have described Mto1-bonsai as the minimal fragment of Mto1 that is capable of 
promoting MT nucleation by the -TuC. However, some nucleation may be retained in more 
extensively truncated mto1 mutants. I showed in chapter 3 that further truncation of the 
Mto1 C-terminus abolishes cytoplasmic MT nucleation, likely by eliminating the Mto1-Mto2 
interaction. More extensive truncation of the Mto1 N-terminus, on the other hand, does 
not appear to completely eliminate MT nucleation. Both mto1(203-549)-GFP and mto1(242-
549)-GFP cells show only limited MT nucleation, but this clearly differs from mto1 cells 
which are completely incapable of nucleating cytoplasmic MTs.  Mto1(203-549)-GFP and 
Mto1(242-549)-GFP have lower steady-state expression levels than Mto1-bonsai-GFP, 
which may account for the reduced nucleation observed in these mutants. Indeed, over-
expression of nmt81:Mto1(203-549)-GFP results in MT nucleation comparable to that seen 
in nmt81:mto1-bonsai-GFP, as determined by MT regrowth experiments. Over-expression 
of nmt81:Mto1(242-549)-GFP has a more modest effect, although it is clear that 
nmt81:mto1(242-549)-GFP cells can in fact nucleate MTs.  Thus, in principle, N-terminal 
truncations smaller than Mto1-bonsai-GFP may be capable of promoting MT nucleation by 
the -TuC. Still, mto1-bonsai remains the smallest mutant identified that is capable of 
robust MT nucleation, when expressed from the endogenous mto1 promoter.  
 Higher-order assemblies of Mto1/2 appear to be responsible for activating the -
TuC.  Fluorescence quantification revealed that MTs were nucleated by -TuCs associated 
with approximately 13 copies each of Mto1-bonsai-GFP and Mto2-GFP. This implies that in 
an actively nucleating -TuC, each -TuSC is associated with roughly 2 copies of Mto1 and 2 
copies of Mto2. Therefore, one might predict that Mto1/2 contributes to -TuC activation 
by promoting -TuSC multimerization. Also, Mto1/2-binding could induce conformational 
changes in the -TuC, which are thought to be necessary for generating an effective -
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tubulin template for MT assembly (Kollman et al., 2011; Kollman et al., 2010). A model for 
-TuC activation by the Mto1/2-bonsai complex is shown in figure 4.16.  
 Recently, a similar study performed in budding yeast determined the stoichiometry 
of -TuC components present at the ends of MTs released from the SPB. MTs were found to 
be associated with 17 -tubulin, 7 Spc97, and 9 Spc98 molecules (Erlemann et al., 2012), 
values which are comparable to those seen here for Alp4 and Alp6. Significantly, however, 
both analyses revealed copy numbers that exceed the 7 -TuSCs that produce a 13 -tubulin 
template in vitro (Kollman et al., 2010). The authors of the budding yeast study proposed 
that the additional  -tubulin and Spc98 may help to stabilize the -TuC or determine the 
site of the MT seam, rather than contributing directly to the -tubulin template (Erlemann 
et al., 2012). A similar model could account for the additional Alp4 and Alp6 molecules 
observed here.   
 Importantly, my fluorescence quantification was performed on -TuCs and Mto1/2-
bonsai complexes that were in the process of nucleating MTs. This allowed me to 
determine the composition of complexes that were "active" and capable of MT nucleation. 
Ideally, I would also like to have determined the composition of complexes that were not 
actively nucleating MTs. This would allow me to address, for example, whether or not 
Mto1/2-bonsai exists primarily as smaller sub-complexes, which promote MT nucleation 
only upon multimerization into higher order assemblies. However, these "non-nucleating" 
particles diffused rapidly around the cell and persisted for only short periods of time, 
making them essentially impossible to accurately identify and quantify. In contrast, the 
actively nucleating puncta were much easier to identify, owing to their clear association 


















5. Mto2 multimerizes Mto1 into higher-order 
complexes that activate the -TuC 
 
5.1 Introduction  
 
 Previous work has indicated that Mto1/2 localization depends on Mto1 but not 
Mto2.   However, in mto2 cells, Mto1 promotes MT nucleation exclusively from the SPB 
(Samejima et al., 2005; Venkatram et al., 2005). This reveals that Mto2 contributes to 
Mto1/2 activation of MT nucleation at non-SPB sites. Because they fail to localize to the 
SPB, the Mto1-NE and Mto1-bonsai mutants therefore provided an opportunity to directly 
assess the role of Mto2 in MT nucleation. Through analysis of Mto1-NE-GFP and Mto1-
bonsai-GFP in an mto2 background, I concluded that Mto2 is required for multimerization 
of Mto1 at sites on the NE, MTs, and free in the cytoplasm. Further, I found that 
multimerization of Mto1/2 into higher-order assemblies is required for MT nucleation.  
 The mto1-NE and mto1-bonsai mutants also allowed me to address the role of 
various MTOCs in nuclear positioning. According to current models, MTs are associated 
with the nucleus via their minus ends. The forces produced as MT plus-ends grow and push 
against the cell cortex are thought to position the nucleus at the centre of the cell (Tran et 
al., 2001). Physical connection of MTs to the nucleus  could be achieved by nucleation of 
MTs from MTOCs on the NE , or alternatively by additional factors that link existing MTs to 
the nuclear surface. Here, I demonstrate that MT nucleation from the NE does in fact 
contribute to nuclear positioning; in mto1(131-1115) and mto1-bonsai cells, where the NE 
no longer acts as a MTOC, nuclei were more eccentric than in wild-type cells. By contrast, 
the lack of MT nucleation from the SPB and existing MTs in mto1-NE had no effect on 
nuclear positioning.  
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 In this chapter, I also analyzed the role of the -TuRC-specific proteins Alp16, Gfh1, 
and Mod21 in MT nucleation in the mto1-NE and mto1-bonsai mutants. Previous work has 
shown that the -TuRC-specific proteins are not required for MT nucleation in wild-type 
cells (Anders et al., 2006). However, individual or simultaneous deletion of Alp16, Gfh1, and 
Mod21 results in a roughly 2-fold reduction in the frequency of MT nucleation, in mto1+ 
cells (Anders et al., 2006).  In mto1-NE and mto1-bonsai, on the other hand, the absence of 
the -TuRC specific proteins has no effect on the frequency of MT nucleation. We propose 
that the -TuSC proteins in association with Mto1/2-bonsai may form a minimal, non-





5.2.1 Higher-order multimerization of Mto1/2 is required for -TuC 
activation   
 
 Mto1-GFP localization to MTs is fairly weak in mto2 cells, showing only faint 
decoration of MTs rather than the more robust, punctate signal observed in the presence 
of Mto2 (Figure 5.1) (Samejima et al., 2005; Venkatram et al., 2005). This led us to 
speculate that Mto2 may have a role in multimerization of Mto1 at iMTOCs. Indeed, in an 
mto2 background, Mto1-NE-GFP and Mto1-bonsai-GFP completely failed to assemble into 
distinct puncta, and instead produced only a diffuse signal (Figure 5.1). Mto1(131-9A1-549)-
GFP also formed puncta in an Mto2-dependent manner, suggesting that multimerization of 
the Mto1/2 complex can occur independent of interaction with the -TuC or localization to 
MTOCs (Figure 5.1). Mto1(131-9A1-549)-GFP showed no specific localization, but rather 
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formed puncta that appeared to diffuse freely throughout the cytoplasm. Notably, 
however, these puncta were less numerous and generally fainter than those observed with 
Mto1-bonsai-GFP, hinting that association with the -TuC may contribute to Mto1/2-bonsai 





 We saw in the previous chapter that MTs were nucleated from puncta containing 
higher-order assemblies of Mto1/2-bonsai (Figure 4.12; Figure 4.14). Therefore, we 
predicted that the apparent lack of Mto1-NE-GFP and Mto1-bonsai-GFP puncta in mto2 
cells would correspond to a lack of MT nucleation. To test this, I made movies of GFP--
tubulin in various mto2+ and mto2 strains. As expected, mto1+ mto2 cells were capable 
of nucleating interphase MTs from the SPB (Figure 5.2)(Samejima et al., 2005; Venkatram et 
al., 2005). In contrast, mto1-NE-GFP mto2 and mto1-bonsai-GFP mto2 mutants failed to 
nucleate any cytoplasmic MTs (no MT nucleation was observed in 50 cells imaged over 500 
seconds) (Figure 5.2). Overall, this suggests that MT nucleation from non-SPB sites requires 
multimerization of Mto1 by Mto2.  
 The absence of MT nucleation in mto1-NE-GFP mto2 and mto1-bonsai-GFP 
mto2cells was confirmed by quantifying numbers of MT bundles. Both mto1-NE-GFP 
mto2 and mto1-bonsai-GFP mto2behaved like mto1,  often having one or no MT 
bundles, indicating a complete lack of cytoplasmic MT nucleation. These strains differed 
from mto1+ mto2 and mto1-GFP mto2, in which MT nucleation from the SPB typically 








5.2.2 Mto2 shows limited multimerization in the absence of Mto1  
 
 Next, I wished to address whether or not Mto1 makes any contribution to Mto2 
multimerization. Previously, it was shown that Mto2-GFP failed to localize to MTOCs in an 
mto1 background, instead being visible as a diffuse signal throughout the cytoplasm 
(Samejima et al., 2005; Venkatram et al., 2005). Here, more sensitive spinning disk confocal 
microscopy was used to address whether or not deletion of mto1 results in disassembly of 
Mto2 puncta. As seen in figure 5.3, faint particles of Mto2-GFP were still detected in mto1 
cells. Generally, these Mto2-GFP puncta showed no specific localization and diffused rapidly 
around the cell, making them difficult to detect. These diffusing particles were in fact Mto2-
GFP, as an imaging control showed some autofluorescence on the GFP channel, but lacked 
discrete puncta (Figure 5.3). Mto2-GFP puncta in mto1 were occasionally observed along 
MTs, perhaps indicating that Mto2 has a very weak affinity for the MT lattice (Figure 5.3). 
Overall, however, it was apparent that robust assembly of Mto2 puncta required the 























5.2.3 MT nucleation from the NE has a minor role in nuclear positioning 
 
 Nuclear positioning in fission yeast is a MT-dependent process (Sawin et al., 2004; 
Tran et al., 2001). Previous work has revealed that MT minus-ends are linked to the nucleus 
via the SPB and additional sites on the nuclear surface, in a process which may involve the 
SPB protein Sad1 (Tran et al., 2001). As MT plus-ends grow and push against the cell cortex, 
they are thought to exert forces that position the nucleus at the centre of the cell (Tran et 
al., 2001). Linkage of MTs to the nuclear surface could be achieved by two general 
mechanisms: MTOCs on the NE and SPB could nucleate and therefore anchor MTs via their 
minus-ends. Alternatively, existing MTs could be captured and attached to the SPB and/or 
NE. 
 I therefore tested if nuclear positioning was affected in the various mto1 truncation 
mutants, where the SPB and/or NE no longer function as cytoplasmic MTOCs. Wild-type 
and truncated mto1 strains were DAPI-stained, and the distances from the centre of the 
nucleus to the nearest cell tip (S) and the farthest cell tip (L) were determined (Figure 5.4). 
The ratio S/L was used as a measure of nuclear positioning, where a value of 1.0 would 
represent a perfectly centred nucleus. Because they have comparable expression levels 
(Figure 4.11), the GFP-tagged versions of the mto1 mutants were used in this experiment.  
 Disrupting localization of Mto1 and the -TuC was found to have a limited effect on 
nuclear positioning. Roughly 60% of cells expressing full-length Mto1-GFP exhibited an S/L 
ratio greater than 0.8 (Figure 5.4). By contrast, nuclei in mto1 showed significant 
displacement from the cell centre (Figure 5.4), as shown previously (Sawin et al., 2004). 
Only 20% of mto1 cells had an S/L ratio greater than 0.8, due to a lack of proper 
cytoplasmic MT organization. However, nuclear positioning in mto1-NE-GFP was essentially 






localization to the SPB and pre-existing MTS, and thereby abolishing cytoplasmic MT 
nucleation from these sites, has no appreciable effect on MT-dependent nuclear 
positioning.  Eliminating NE localization in mto1(131-1115)-GFP and mto1-bonsai-GFP, on 
the other hand, had a moderate effect on nuclear positioning, with roughly 40% of cells 
having an S/L ≥ 0.8 (Figure 5.4).  MT nucleation from MTOCs on the NE therefore 
contributes at least somewhat to ensuring correct nuclear positioning.  
 
5.2.4 mto1-NE-GFP and mto1-bonsai-GFP nucleate MTs in the absence 
of -TuRC-specific proteins 
 
 The -TuRC-specific proteins Alp16, Gfh1, and Mod21 are not essential for MT 
nucleation, but appear to enhance the MT-nucleating activity of the -TuC; alp16 gfh1 
mod21 cells retain the ability to nucleate MTs, but nucleate at a reduced frequency 
(approximately half the frequency of wild-type cells)(Anders et al., 2006). Moreover, in the 
absence of Alp16, Gfh1 and Mod21 fail to interact with the -TuSC, such that alp16 cells 
can effectively be regarded as alp16 mod21 gfh1 triple deletion mutants.  
 We wanted to confirm that the -TuRC-specific proteins were also dispensable for 
MT nucleation in mto1-NE and mto1-bonsai cells. Therefore, I made movies of GFP--
tubulin in cells expressing Mto1-GFP, Mto1-NE-GFP, or Mto1-bonsai-GFP in an alp16 
background, and quantified nucleation events as before. As expected, the frequency of MT 
nucleation in mto1-GFP alp16 was clearly reduced when compared to mto1-GFP alp16+ 
cells (Figure 5.5). In mto1-NE-GFP and mto1-bonsai-GFP, however, deleting alp16 had no 
appreciable effect on the frequency of MT nucleation (Figure 5.5). This suggests that the -
TuRC-specific proteins make no obvious contribution to MT nucleation in mto1-NE or mto1-








 In cells lacking Mto2, Mto1-NE and Mto1-bonsai puncta are no longer observed.  
This results in a complete lack of cytoplasmic MT nucleation, highlighting the importance of 
Mto1 multimerization in -TuC activation. However, MT nucleation from the SPB is 
preserved in mto2 cells expressing full-length Mto1, as shown in previous studies 
(Samejima et al., 2005; Venkatram et al., 2005). Thus, Mto2 may be specifically required for 
multimerizing Mto1 at iMTOCs on MTs, the NE, and free in the cytoplasm. Additional, 
redundant factors at the SPB could be responsible for multimerizing Mto1 in an Mto2-
independent manner.  
 The notion that Mto2 promotes Mto1 multimerization also helps us interpret 
observations regarding Mto1 localization. In the absence of Mto2, localization of full-length 
Mto1 to the SPB is unaffected, although localization to MT bundles is clearly reduced 
(Samejima et al., 2005; Venkatram et al., 2005). Further, Mto1 is completely absent from 
the NE in an mto2 background, a phenomenon clearly demonstrated by comparison of 
mto1-NE-GFP and mto1-NE-GFP mto2 cells. In principle, Mto2 could contribute to Mto1 
localization to MTs and the NE in at least two ways. First, Mto2 itself could contain 
sequences which help target Mto1/2 to MTs and the NE. This is unlikely, however, due to 
the lack of Mto2 localization to these MTOCs in an mto1 background. The second, perhaps 
more plausible explanation is that multimerization of Mto1 by Mto2 increases the avidity of 
the Mto1/2 complex for sites on MTs and the NE. This explanation is consistent with the 
idea that Mto1 is the predominant factor involved in localizing the Mto1/2 complex and -
TuC to MTOCs.  
 In this chapter, we also demonstrated that MT nucleation from MTOCs on the NE 
contributes to  nuclear positioning. This is in line with the view that physical linkage 
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between MTs and the NE is required to position the nucleus at the centre of the cell (Tran 
et al., 2001). Eliminating the NE as a MTOC in the mto1 N-terminal truncations, however,  
had a much milder effect on nuclear positioning than completely abolishing cytoplasmic MT 
nucleation in mto1 cells. Even in mto1-bonsai cells, where MT nucleation is spatially 
random, nuclei were only somewhat more eccentric than in wild-type cells. Simply 
maintaining cytoplasmic MT arrays, therefore, appears to be more important to nuclear 
positioning than nucleating MTs from the NE. Overall, this suggests that other factors, in 
addition to MTOCs on the NE, must link the MT cytoskeleton to the nuclear surface.  
 Finally, this chapter revealed that the -TuRC-specific proteins Alp16, Gfh1, and 
Mod21 are not required for MT nucleation in mto1-bonsai-GFP.  This suggests that 
complexes composed solely of Mto1/2-bonsai and -TuSCs may be sufficient for MT 
nucleation. Owing to its simplicity, this is an attractive model for a minimal MT-nucleating 
complex, that functions independent of localization to conventional MTOCs. Nonetheless, 



























6. Recombinant Mto1/2-bonsai complex self-
assembles into large multimers 
 
6.1 Introduction  
  
 In the preceding chapters, I provided evidence that the Mto1/2 complex is a -TuC 
activator.  We suspect that Mto1/2-bonsai in association with -TuSCs may be sufficient for 
MT nucleation. However, the possibility that other proteins are also required for MT 
nucleation can never be formally excluded by in vivo studies. Ultimately, identification of 
the minimal components that are sufficient for robust physiological MT nucleation will 
require in vitro reconstitution of an actively-nucleating complex.  
 Towards this more long-term objective, I expressed and purified Mto1-bonsai and 
Mto2 individually, and also together as the Mto1/2-bonsai complex. To do this, I employed 
the MultiBac system, a baculovirus expression system developed by Imre Berger and 
colleagues (Berger et al., 2004; Bieniossek and Berger, 2009; Fitzgerald et al., 2006; 
Fitzgerald et al., 2007; Trowitzsch et al., 2010). The MultiBac system is specifically designed 
for the expression of multiprotein complexes. Multiple  genes of interest (GOIs) are cloned 
into a transfer vector, which is then  integrated into the MultiBac Bacmid (a baculovirus 
shuttle vector that can be propagated in both E. coli and insect cells). Transfection of the 
recombinant Bacmid into insect cells then allows for virus production and, ultimately, 
protein expression. GOIs can easily be added to existing MultiBac transfer vectors, using 
conventional cloning techniques or by Cre-LoxP fusion with "donor vectors" carrying 
additional GOIs (Trowitzsch et al., 2010). This means that one can easily express various 
combinations  (or truncations) of proteins from a multiprotein complex, and also add 
additional components at a later date.  
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 I used the MultiBac system to co-express Mto2 together with full-length Mto1, 
Mto1-NE, or Mto1-bonsai. Mto1-bonsai showed the most robust expression, and further 
analysis was therefore limited to Mto1-bonsai and Mto2. Using N-terminal 6-histidine tags, 
Mto1-bonsai, Mto2, and Mto1/2-bonsai complex were Nickel-purified. Following a 
subsequent gel filtration step, the individual proteins and protein complex could be 
obtained with roughly 95% purity. 
 Size exclusion chromatography with multi-angle light scattering (SEC-MALS) 
revealed that Mto1/2-bonsai complex eluted as a broad peak containing complexes ranging 
in size from  ~75-800 kDa. This large size-range across a single peak suggested that Mto1/2-
bonsai was in a dynamic equilibrium between complexes with various degrees of 
multimerization. Indeed, dilution of the sample caused Mto1/2-bonsai to elute later, 
indicating a shift in equilibrium towards disassembly into smaller multimers. A similar effect 
was seen with Mto2 alone, indicating that Mto2 also multimerizes and is in a dynamic 
equilibrium. By contrast, in the absence of Mto2, Mto1-bonsai appeared to be 
monodisperse. In addition, I found that Mto1-bonsai and Mto2 purified separately were 





6.2.1 Mto1/2-NE and Mto1/2-bonsai are expressed at higher levels in 
insect cells than full-length Mto1/2 
 
 Initially, I constructed bacmids  for the co-expression of 6His-Mto1, 6His-Mto1-NE, 
or 6His-Mto1-bonsai  together with Mto2. I generated various constructs of Mto1 because 
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we suspected that the smaller Mto1 truncations might be expressed at higher levels than 
full-length Mto1. The various bacmids were transfected into Sf9 insect cells to generate 
virus stocks, and the approximate titre of virus stocks was then determined (see materials 
and methods). Suspension cultures of Sf9 cells were infected with equal amounts of each 
virus, and total and soluble expression of Mto1 and Mto2 was monitored by western 
blotting for 4 days following infection (Figure 6.1). In all cases, Mto2 expression appeared 
to peak after 2-3 days, and essentially all Mto2 appeared to be soluble. Similarly, Mto1-NE 
and Mto1-bonsai expression also peaked around 3 days, and both proteins appeared to be 
entirely soluble. However, full-length Mto1 appeared to show much weaker expression. 
The Mto1 band was fainter in comparison to background signal, perhaps indicating that it 
was largely degraded. All three anti-Mto1 western blots were performed with serum, 
rather than affinity-purified antibodies, such that some non-specific bands were likely 
present in all cases. However, with full-length Mto1, additional high molecular weight 
bands were observed, which were absent from the Mto1-NE and Mto1-bonsai blots (Figure 
6.1).   These high molecular weight bands likely corresponded to degradation of full-length 
Mto1. Further, only a fraction of Mto1 appeared to be soluble, and the amount of soluble 
Mto1 did not appear to increase beyond one day post-infection. Therefore, I decided to 
pursue Mto1/2-bonsai for further analysis — this complex clearly showed better expression 






6.2.2 6His-Mto1/2-bonsai has a particularly high-affinity for nickel 
 
 In developing a protocol for nickel-purification of 6His-Mto1/2-bonsai, I first sought 
to determine the range of imidazole concentrations in which the complex would bind to Ni-
charged beads. Soluble lysate from Sf9 cells expressing 6His-Mto1-bonsai and Mto2 was 
incubated with Ni-charged His-Bind Fractogel, in the presence of increasing concentrations 
of imidazole. Samples of the supernatant were analyzed by western blot, in order to 
quantify the amount of unbound 6His-Mto1-bonsai and Mto2. The recovery of both 
proteins following elution from the beads was also analyzed by western blot (Figure 6.2). 








even at 60-90 mM imidazole. Mto2 recovery was also efficient at relatively high imidazole 
concentrations of 30-60 mM. We took this as an initial indication that recombinant Mto1/2-
bonsai may be multimerized; the presence of multiple 6His tags on a single complex would 
increase the avidity of the complex for Ni-charged beads, and allow for binding at relatively 
high imidazole concentrations.  
 I was therefore able to perform nickel purifications under fairly stringent conditions 
(45 mM and 90 mM imidazole in binding and wash buffers, respectively; see materials and 
methods). This allowed me to partially purify 6His-Mto1/2-bonsai complex, in addition to 
6His-Mto1-bonsai and 6His-Mto2 individually (Figure 6.3). Co-purification of un-tagged 







6.2.3 Recombinant Mto1/2-bonsai forms a range of complexes roughly 
75-800 kDa in size 
 
 As a second purification step, Ni-purified Mto1/2-bonsai complex was fractionated 
by gel filtration on a Superose 6 10/300 GL column. The  Mto1/2-bonsai complex eluted 
over a relatively broad range, with a peak elution volume of roughly 10.5 mL. The purity in 
the peak fractions was estimated to be about 95%, with most contaminants present either 
in the void volume or in low molecular weight fractions (Figure 6.4A).  
 Quantification from coomassie-stained gels revealed that Mto1-bonsai and Mto2 
co-migrated with an approximately 1:1 stoichiometry during gel-filtration (Figure 6.4B). This 
was consistent with the 1:1 stoichiometry of Mto1-bonsai-GFP and Mto2-GFP observed in 
the MT nucleating puncta described in chapter 4 (Figure 4.14). This also suggested that 
recombinant Mto1/2-bonsai complex was composed of a stable core subunit, such as an 
Mto1/2-bonsai heterodimer or heterotetramer, that failed to dissociate when subjected to 
gel filtration. Further, the broad elution profile of the complex suggested that species of 
different sizes were present, hinting that Mto1/2-bonsai may exist in a variety of multimeric 
states.  
 In order to determine the absolute size of the complex, Mto1/2-bonsai was 
analyzed by SEC-MALS.  The peak Mto1/2-bonsai fractions from a Superose 6 run (10.0-10.5 
mL) (Figure 6.4) were pooled and run again over a Superose 6 column  with online MALS 
detection [SEC-MALS analysis was performed by Martin Wear].  Mto1/2-bonsai was found 
to be highly polydisperse, with complexes ranging from approximately 75-800 kDa 
observed across the Mto1/2-bonsai peak (Figure 6.5). Given the 1:1 stoichiometry of Mto1-
bonsai and Mto2 (Figure 6.4), the smaller 75 kDa complexes were fairly consistent with an 
Mto1/2-bonsai heterodimer (both proteins are approximately 45 kDa). By the same logic, 
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the largest ~800 kDa complexes would be predicted to contain ~9 copies each of Mto1-
bonsai and Mto2. Therefore, these higher-order assemblies are comparable in size to the 
nucleating puncta observed in vivo by fluorescence microscopy, which contained ~13 copies 









6.2.4 The Mto1/2-bonsai complex is in a dynamic equilibrium 
 
 Because the Mto1/2-bonsai peak contained species with a broad range of 
molecular weights, we suspected that the Mto1/2-bonsai complex may be in a dynamic 
equilibrium between multimers of various sizes. If this were true, then dilution of the 
Mto1/2-bonsai complex would lead to disassembly of the complex into smaller multimers. 
This would result in a shift towards later elution during gel filtration.  To test this, 
"undiluted" (~20 M) Mto1/2-bonsai complex was ran over a Superose 6 column, followed 
by 10- and 100-fold dilutions of the same sample. Dilution clearly resulted in a shift towards 
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later elution, suggesting disassembly of the complex into smaller subunits; relative to the 
undiluted sample, 10- and 100-fold dilution increased the elution volume by roughly 1 and 
2.5 mL, respectively (Figure 6.6A). This indicates that the Mto1/2-bonsai complex is indeed 
in a dynamic equilibrium.  
 This dilution-induced shift toward smaller complexes was confirmed by SDS-PAGE 
and coomassie staining or western blot analysis of the fractions  from gel filtration (Figure 
6.6B). The Mto1-bonsai and Mto2 bands in the 10-fold diluted sample were only faintly 
detectably by coomassie staining, but still appeared to co-fractionate, suggesting that some 
sort of Mto1/2-bonsai subunit remained intact. That is, interaction between Mto1-bonsai 
and Mto2 was preserved upon dilution, despite the disassembly of higher-order Mto1/2-
bonsai complexes. Similarly, in the 100-fold dilution, Mto1-bonsai and Mto2 appeared to 
peak in the same fraction (12.5 mL) as determined by immunoblotting, although the signal 
on these blots was very faint (Figure 6.6B). This may imply that higher-order multimers of 
Mto1/2-bonsai are assembled from a core, heteromeric subunit consisting of both Mto1-








6.2.5 Mto2 multimerizes and is in a dynamic equilibrium, while Mto1-
bonsai is likely monodisperse 
 
 
 I wished to address if either Mto1-bonsai or Mto2, when purified individually, was 
also multimerized and in a dynamic equilibrium. I therefore performed the same analysis as 
with the Mto1/2-bonsai complex, running various concentrations of Mto1-bonsai and Mto2 
individually on a Superose 6 column. Mto2 showed a clear shift to later elution when 
diluted (Figure 6.7) (undiluted sample was approximately 50 M).  When diluted 10- and 
100-fold, Mto2 was found to elute about 0.5 and 1.0 mL later, respectively. This reveals 
that Mto2 is in a dynamic equilibrium and therefore must be multimerized to at least some 
degree. Mto1-bonsai, by contrast, showed only a very modest (and possibly negligible) shift 
upon 10-fold dilution, and an even less apparent shift when diluted 100-fold (Figure 6.8). 
This suggests that Mto1-bonsai is likely monodisperse when purified alone, and assembles 
into more dynamic, higher-order assemblies only upon association with Mto2.  
 Next, I wanted to know if Mto1-bonsai and Mto2 were able to assemble into 
Mto1/2-bonsai complex in vitro. To test this, Mto1-bonsai and Mto2 were purified 
separately, and subsequently combined. Gel filtration on a Superose 6 column was then 
used to analyze the individual and combined proteins. When run individually, Mto1-bonsai 
and Mto2 were found to elute around 13.5 and 12.5 mL, respectively (Figure 6.9A). When 
combined and ran together, however, both proteins eluted as a broad peak centred around 
11.5 mL, indicating multimerization into Mto1/2-bonsai complex (Figure 6.9A). SDS-PAGE 
and coomassie staining confirmed that Mto1-bonsai and Mto2 co-fractionated as Mto1/2-
bonsai complex when combined (Figure 6.9B). Overall, this reveals that Mto1-bonsai and 
Mto2 have the intrinsic ability to self-assemble into higher-order complexes, outside of a 



















 The fact that recombinant Mto1/2-bonsai assembles into large, dynamic multimers 
is consistent with observations of endogenous fission yeast Mto1/2 complex and likely 
relates to its function. SEC-MALS analysis of the recombinant complex suggests that 
Mto1/2-bonsai heterodimers associate to form multimers with a range of sizes. At about 
800 kDa, the largest of these multimers would correspond to ~9 copies each of Mto1-
bonsai and Mto2. These values are comparable to the 13 copies of Mto1-bonsai-GFP and 
Mto2-GFP observed in nucleating puncta by fluorescence microscopy. In addition, 
fluorescence microscopy of nucleating puncta and biochemical analysis of recombinant 
Mto1/2-bonsai both suggest that Mto1-bonsai and Mto2 associate with a 1:1 
stoichiometry. Consistent with this, endogenous Mto1(1-800) and Mto2 from fission yeast 
extracts may form a heterotetramer, as determined by hydrodynamic analysis (Lynda M. 
Groocock, PhD Thesis 2010). Overall, the data therefore suggest that Mto1 and Mto2 
associate in a core subunit, such as a heterodimer or heterotetramer, which then 
multimerizes into larger complexes. As we saw in chapter 4, higher-order multimers of 
Mto1/2-bonsai may activate MT nucleation from the -TuC. Significantly, this 
multimerization  is preserved in purified, recombinant Mto1/2-bonsai complex.  
 The oligomeric states of Mto1-bonsai and Mto2 when purified individually were 
less clear. Previous work has shown that Mto1 and Mto2 self-interact in vivo, and that 
recombinant Mto2 (expressed in E. coli, where it is poorly soluble) may be pentameric 
(Lynda M. Groocock, PhD Thesis 2010). Here, the dilution experiments with recombinant 
Mto2 from insect cells clearly show that Mto2 is in a dynamic equilibrium, confirming that 
Mto2 must be multimerized to some extent. Mto1-bonsai, on the other hand, appeared to 
be monodisperse. From gel filtration alone, we cannot directly infer the oligomeric state of 
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Mto1-bonsai or Mto2, given the dependence of elution volume on additional features such 
as molecular shape and non-specific interaction with the column matrix. However, we can 
make some general predictions regarding Mto1-bonsai and Mto2 oligomerization, based on 
the typical migration of calibration proteins  on Superose 6 (as described by GE Healthcare 
in protocols provided with the Superose 6 10/300 GL column). For example, bovine serum 
albumin (BSA), a globular protein of 67 kDa, is expected to elute around 16 mL. By contrast 
Mto1-bonsai and Mto2, which would both be 45 kDa as monomers, elute much earlier — 
Mto1-bonsai elutes at 13.5 mL, while Mto2 elutes around 12-13 mL (depending on 
concentration). These elution volumes fall between those generally expected for 
thyroglobulin and ferritin, which have molecular weights of 660 and 440 kDa, respectively. 
Overall, this implies that Mto1-bonsai, as well as Mto2, is very likely multimerized to some 
unknown degree. Given that it contains coiled-coils, we might predict that Mto1-bonsai is 
at least dimeric. However, this is somewhat inconsistent with the SEC-MALS data for the 
Mto1/2-bonsai complex, which suggests that Mto1-bonsai and Mto2 elute partly as 
heterodimers. It is possible that binding of Mto1-bonsai to Mto2 disrupts Mto1-Mto1 and 
Mto2-Mto2 self-interaction, although this seems unlikely. Ultimately, a technique such as 
SEC-MALS will be required to accurately determine the oligomeric states of Mto1-bonsai 














7. Conclusions and Future Work 
 
 Throughout this study, I have attempted to characterize the role of Mto1/2 in 
activating the -TuC, while also adding to our knowledge of how Mto1/2 targets the -TuC 
to cytoplasmic MTOCs. Primarily, this was done through analysis of the mto1-NE and mto1-
bonsai mutants. Also, as a first step towards reconstituting MT nucleation in vitro, I 
expressed, purified, and characterized recombinant Mto1/2-bonsai complex. 
 Very little is known about the factors involved in regulating MT nucleation by the -
TuC, making the identification of -TuC activators a subject of particular interest. Currently, 
CDK5RAP2 remains the only protein which has been shown to have a direct role in 
activating the -TuC (Choi et al., 2010). CDK5RAP2 is also involved in recruiting the -TuC to 
the centrosome and, like Mto1, associates with the -TuC via a CM1 domain (Choi et al., 
2010; Fong et al., 2008). In vivo, over-expression of a CM1-containing fragment of 
CDK5RAP2 displaces the -TuC from the centrosome, and results in extensive acentrosomal 
nucleation (Choi et al., 2010). However, it is uncertain if the MT nucleation observed under 
conditions of CDK5RAP2 over-expression occurs by a physiologically relevant mechanism. 
Indeed, cells over-expressing the CM1 fragment of CDK5RAP2 nucleate MTs in an abnormal 
manner, with many short MTs appearing throughout the entire cytoplasm.  In vitro, both 
full-length CDK5RAP2 and the CM1-containing fragment are capable of activating MT 
nucleation from purified -TuRCs (Choi et al., 2010). Still, the mechanism by which 
CDK5RAP2 stimulates MT nucleation by the -TuRC remains unknown.  
 In the present work, I have provided strong evidence that the Mto1/2 complex is 
also a -TuC activator. Previous work has shown that in the absence of Mto1, the -TuC is 
no longer localized to cytoplasmic MTOCs and cells are completely deficient in cytoplasmic 
MT nucleation (Sawin et al., 2004; Venkatram et al., 2004). However, this did not tell us 
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whether or not Mto1/2 had a direct role in -TuC activation — it remained possible that 
Mto1/2 is responsible only for localizing the -TuC to MTOCs, where additional factors then 
activate -TuC.  For example, kinases or structural proteins that are specifically localized to 
MTOCs could be required for activating the -TuC. To address this issue, I therefore 
generated the Mto1-bonsai mutant, which lacked the N- and C-terminal domains required 
for localizing the Mto1/2 complex and -TuC to cytoplasmic MTOCs. Significantly, the 
Mto1/2-bonsai complex is able to promote spatially random MT nucleation from the -TuC. 
This suggests that Mto1/2 has a direct role in activating the -TuC, that is independent of its 
role in localizing the -TuC to MTOCs. Consistent with this, live-cell imaging revealed that 
newly-nucleated MTs are always associated with Mto1-bonsai and Mto2, in addition to the 
-TuC. This confirmed that actively-nucleating -TuCs are associated with Mto1/2-bonsai 
complexes. Overall, the mto1-bonsai mutant  provides the strongest evidence to date that 
Mto1/2 is a -TuC activator. However, we cannot rule out the possibility that additional 
proteins are also required for activating the -TuC by in vivo analysis alone. That is, 
additional -TuC-associated proteins that are required for MT nucleation may simply remain 
to be identified.  
 Importantly, mto1-bonsai has qualitatively normal MT arrays and shows only very 
minor defects in MT-dependent processes such as nuclear positioning and maintenance of 
cell morphology. These processes require that MTs are oriented with minus-ends 
overlapping at the cell centre and plus-ends towards the cell tips. This allows MTs to 
correctly target polarity factors to cell tips, and also to exert forces on the nucleus to 
position it at the centre of the cell. mto1-bonsai appears to be able to maintain this 
orientation of MTs, despite lacking any conventional MTOCs. This could be confirmed by 
imaging a MT plus-end tracking protein, such as GFP-tagged Mal3 (Busch and Brunner, 
2004), in an mto1-bonsai background. Following spatially random MT nucleation in mto1-
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bonsai, proper MT organization is likely ensured by additional factors, including the MT 
bundling proteins Ase1 and Dis1, as well as motor proteins such as Klp2 (Roque et al., 2010; 
Yamashita et al., 2005). The minus-end directed motor Klp2 and anti-parallel bundling 
protein Ase1 act cooperatively to orient MTs with plus-ends towards the cell tips and 
minus-ends overlapping at the cell centre (Braun et al., 2011; Roque et al., 2010).  In fact, 
cells completely lacking nuclei and SPBs are capable of  organizing and correctly orienting 
MTs in this manner (Carazo-Salas and Nurse, 2006; Daga et al., 2006). Notably, MT 
nucleation in these anucleate cells was found to be spatially random and Mto1-dependent. 
The mechanism for this spatially random nucleation is clearly explained here, using the 
mto1-bonsai mutant. Overall, the findings in anucleate cells and mto1-bonsai may lead us 
to question the functional purpose of nucleating MTs from specific subcellular sites. 
Perhaps, the function of site-specific MT nucleation is simply redundant with the MT 
organization achieved by bundling factors and motor proteins.  
 In both mto1-NE and mto1-bonsai, existing MTs no longer appear to function as 
MTOCs. The lack of MT nucleation from existing MTs has no obvious effect on these cells: 
mto1-NE cells are perfectly viable, and exhibit wild-type polarity and nuclear positioning. 
Polarity and nuclear positioning defects only arise when MT nucleation from the NE is 
eliminated in mto1-bonsai and mto1(131-1115). MT-based MT nucleation in fission yeast 
may simply "amplify" existing MT bundles. This type of MT nucleation from the sides of 
existing bundles is important in other organisms. In Drosophila and human cells, the 8 
subunit augmin complex has been show to recruit the -TuC to MTs within the mitotic 
spindle (Goshima et al., 2008; Uehara et al., 2009). This promotes MT nucleation from 
existing spindle MTs, thereby increasing the density and stability of the mitotic spindle. 
Augmin-dependent MT nucleation within the spindle also appears to increase the 
frequency of kinetochore capture (Goshima et al., 2008). Augmin depletion in Drosophila S2 
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cells is largely rescued by centrosome-mediated MT nucleation (Goshima et al., 2008), 
which itself depends on the CM1 protein Centrosomin (Megraw et al., 1999; Zhang and 
Megraw, 2007). By contrast, augmin depletion in human HeLa cells leads to severe spindle 
defects and metaphase arrest (Uehara et al., 2009).  
 The mto1-NE mutant will likely prove useful in understanding how the NE acts as a 
MTOC in fission yeast. The role of the NE as a MTOC is of interest in other systems as well.   
For example, the NE acts as a MTOC in differentiated muscle cells, referred to as myotubes. 
Myotubes are multinucleate cells, that form by the fusion of several myoblasts. During this 
differentiation process, centrosomal proteins such as -tubulin, pericentrin, and ninein re-
distribute to the NE, thus establishing the NE as a site of MT nucleation (Bugnard et al., 
2005; Tassin et al., 1985). In plants, which lack centrosomes, the NE acts as a primary MTOC 
(Seltzer et al., 2007; Stoppin et al., 1994). Arabidopsis -tubulin, GCP2, and GCP3 localize to 
the NE, and deletions within GCP2 and GCP3 abolish this localization (Seltzer et al., 2007). 
Precisely how the -TuC associates with the nuclear surface in plant cells remains unclear, 
although we might predict that this requires -TuC binding to some sort of anchoring 
complex on the NE. Mto1-NE may help us identify anchoring proteins of this sort. When 
compared to wild-type Mto1, Mto1-NE shows greatly increased localization to the nuclear 
surface. Thus, pull-down experiments with Mto1-NE could facilitate the identification of 
proteins which are specifically involved in linking the Mto1/2 complex to the nuclear 
surface.  
 Further analysis of the mto1-bonsai mutant allowed us to propose a general model 
for how Mto1/2 may activate the -TuC. Previously, sucrose gradients have revealed that 
the vast majority of fission yeast -tubulin is present in small complexes, suggesting that 
fission yeast cells contain only limited numbers of -TuRCs (Anders et al., 2006). Through 
fluorescence quantification of nucleating puncta, I found that actively-nucleating -TuCs are 
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associated with ~13 copies each of Mto1-bonsai and Mto2. The value 13 matches the 
number of protofilaments in a MT, and also the number of -tubulins thought to be present 
in a single -TuRC. We found that nucleating puncta contained ~8 copies each of Alp4-GFP 
and Alp6-GFP, values which are consistent with single -TuRCs. Overall, these values 
indicate that each -TuSC in an active -TuC associates with ~2 copies each of Mto1-bonsai 
and Mto2. Therefore, we propose that Mto1/2-bonsai may help promote the 
multimerization of -TuSCs into active -TuRCs.  
 Higher-order multimers of Mto1/2 appear to be required for activating the -TuC. 
Deletion of mto2 results in the disappearance of Mto1-NE-GFP and Mto1-bonsai-GFP 
puncta. In the absence of these puncta, which correspond to Mto1/2-NE and Mto1/2-
bonsai multimers, cells are completely deficient in cytoplasmic MT nucleation. Importantly, 
in the absence of Mto2, full-length Mto1 retains normal localization to the SPB and can 
promote MT nucleation from the SPB  (Samejima et al., 2005; Venkatram et al., 2005)(this 
study). This demonstrates that Mto2 is not required for MT nucleation per se. Rather, the 
main role of Mto2 may be in multimerizing Mto1 at non-SPB MTOCs. A redundant 
mechanism of multimerization could allow full-length Mto1 to stimulate MT nucleation at 
the SPB. Local concentration of Mto1 at the SPB, for example, could be sufficient for 
promoting Mto1 multimerization. However, because they fail to localize to the SPB, Mto1-
NE and Mto1-bonsai are completely dependent on Mto2 for assembly into the higher-order 
complexes required for MT nucleation.  
 Based on EM  structural data, it has been proposed that activation of the -TuC may 
also require a conformational change in GCP3. This conformational change would adjust the 
spacing of -tubulins to match the spacing of adjacent protofilaments in the MT lattice 
(Kollman et al., 2011; Kollman et al., 2010). Perhaps, binding of Mto1/2-bonsai at each -
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TuSC in a complete -TuRC could induce this conformational change, thus producing an 
effective template for MT nucleation.  
 Cells may regulate Mto1/2 multimerization as a means of controlling cytoplasmic 
MT nucleation throughout the cell cycle. Previous work has revealed that Mto2 is 
phosphorylated throughout the cell cycle and hyperphosphorylated during mitosis (Lynda 
Groocock, PhD Thesis). The mitotic phosphorylation of Mto2 is correlated with disruption of 
the Mto1-Mto2 interaction and disassembly of Mto1/2 puncta (Lynda Groocock, PhD 
Thesis). This suggests that Mto2 phosphorylation may cause Mto1/2 multimers to 
disassemble during mitosis, leading to inactivation of cytoplasmic -TuCs and  
depolymerization of cytoplasmic MT arrays. This is an attractive model that remains to be 
directly demonstrated. That is, current data shows only a correlation between Mto2 
hyperphosphorylation, disassembly of Mto1/2 multimers, and the depolymerization of 
cytoplasmic MTs during mitosis.  
 The budding yeast proteins Spc72 and Spc110 also appear to associate with the -
TuC as multimers. Spc72 and Spc110 mediate -TuC attachment to the nucleoplasmic and 
cytoplasmic face of the SPB, respectively (Knop and Schiebel, 1997; Knop and Schiebel, 
1998). Recent work in Elmar Schiebel's lab (publish during this thesis work) indicates that 
MTs nucleated from -TuCs on the nucleoplasmic or cytoplasmic face of the SPB are 
associated with ~15 copies of Spc72 or Spc110 (Erlemann et al., 2012). These values are 
comparable to the 13 copies of Mto1-bonsai and Mto2 per -TuC seen here, and similarly 
suggest that Spc72 and Spc110 may act as a scaffold for -TuSC multimerization and 
activation. Notably, the SPB acts as the only MTOC in budding yeast, which lack an Mto2 
homologue. One might suspect, therefore, that Spc72 and Spc110 must be multimerized by 
association with the SPB in order to promote MT nucleation from the -TuC — a similar 
mechanism as described for Mto1 in mto2 cells. Thus, a lack of Spc110 multimerization in 
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vitro could account for the inability of Spc110 to enhance MT nucleation from purified -
TuSCs (Kollman et al., 2010; Vinh et al., 2002). Perhaps, multimerization of purified Mto1-
bonsai by Mto2 will be sufficient for generating a potent activator of the -TuC.  
 Ultimately, confirming that Mto1/2 is a -TuC activator will require reconstitution of 
a complex that is capable of robust MT nucleation in vitro. We suspect that complexes 
composed of Mto1/2-bonsai and the -TuSC proteins may be sufficient for nucleating MTs. 
Towards the long-term objective of demonstrating this, I purified Mto1/2-bonsai complex 
using the MultiBac insect cell expression system. Features of the Mto1/2-bonsai complex 
that were observed in vivo appeared to be conserved in the recombinant complex. Purified 
Mto1/2-bonsai complex had a 1:1 stoichiometry of Mto1-bonsai:Mto2. Further, SEC-MALS 
revealed that Mto1/2-bonsai assembled into multimers with a range of sizes, the largest of 
which were consistent with ~9 copies each of Mto1-bonsai and Mto2. Therefore, these 
complexes are comparable to the nucleating puncta observed by fluorescence microscopy, 
which contained 13 copies each of Mto1-bonsai and Mto2. Importantly, only actively 
nucleating Mto1/2-bonsai puncta were included in fluorescence quantification. This likely 
explains why the Mto1/2-bonsai complex appeared to have a relatively defined size in vivo, 
while recombinant Mto1/2-bonsai complex showed a much wider range of  sizes in vitro.  
 The precise oligomeric states of Mto2 and Mto1-bonsai purified on their own 
remain unknown. Gel filtration experiments revealed that the elution volume of Mto2 was 
increased upon dilution, indicating that Mto2 must be multimerized to some degree. 
Similar experiments suggested that Mto1-bonsai is monodisperse, although based on its 
elution volume I argued that Mto1-bonsai is unlikely to be monomeric. Because it contains 
coiled-coil sequences, we suspect that Mto1-bonsai is at least dimerized. SEC-MALS would 
be ideal for confirming the multimerization states of Mto1-bonsai and Mto2, although 
additional techniques such as  analytical ultracentrifugation could also be used. If it is 
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indeed monodisperse, Mto1-bonsai could be amenable to structural analysis by X-ray 
crystallography.  
 Given its large size (ie. 100s of kDa) the Mto1/2-bonsai complex is a good candidate 
for structural studies by single particle electron microscopy. It would be interesting to see if 
Mto1/2-bonsai forms ring-like or helical structures — the sorts of structures one might 
predict to template -TuSC multimerization. However, the polydispersity of recombinant 
Mto1/2-bonsai complex could complicate this analysis. Gel filtration and SEC-MALS 
experiments demonstrate that Mto1/2-bonsai is in a dynamic equilibrium of complexes 
with a large distribution of molecular weights (~75-800 kDa). Perhaps, varying buffer 
conditions, such as salt or pH, could increased the homogeneity of the complex by 
promoting assembly or disassembly. Also, it is possible that the full-length Mto1/2 complex 
would show reduced polydispersity. The additional coiled-coils in full-length Mto1 
(compared to truncated Mto1-bonsai) could promote more stable, robust multimerization 
into higher-order complexes. However, purification of full-length Mto1 could be 
complicated by the fact that it appears to be extensively degraded. Given that Mto1/2 
forms multimers, degraded products of Mto1 would likely co-purify with full-length, 
undegraded Mto1. Still, purification and characterization of recombinant wild-type Mto1/2 
is certainly worth pursuing.  
 Ultimately, our greatest interest lies in reconstitution of complexes composed of 
Mto1/2-bonsai  and -TuSCs. Given the versatility of the MultiBac system, viruses for the 
co-expression of  Mto1-bonsai, Mto2, Alp4, Alp6, and -tubulin could certainly be 
constructed. MultiBac has been successfully used to express many different protein 
subunits from a single virus genome. For example, the entire 13-protein anaphase 
promoting complex (APC/C) was reconstituted by co-infecting insect cells with 2 MultiBac 
viruses, one encoding 8 proteins and the other encoding 5 proteins (Schreiber et al., 2011). 
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Alternatively, Mto1/2-bonsai and -TuSCs could be expressed and purified separately, and 
later combined in vitro. This latter approach would likely be preferable, as it would allow 
both sub-complexes to be characterized individually and in combination. One could 
address, for example, whether or not Mto1/2-bonsai is capable of promoting -TuSC 
multimerization. Most importantly, reconstitution of these complexes would allow us to 
directly address whether or not Mto1/2-bonsai is sufficient for activating MT nucleation 
from the -TuC. The identification and characterization of Mto1/2-bonsai as a -TuC 
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